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Summary 
 
The purpose of this Bachelor’s thesis “Protein production and purification of 
type II transmembrane protease Tmprss2 in Pichia pastoris (Komagataella 
phaffii)” is to assess optimization possibilities for production and purification 
methods of mouse Tmprss2 in Pichia pastoris. The aim of the thesis was to 
develop upstreaming and downstreaming strategies capable of producing 2 mg 
amounts of properly folded and active Tmprss2 for crystallization experiments. 
Solving the crystal structure of Tmprss2 and the enzyme-substrate interaction 
surface in combination with Hemagglutinin 1 could lead to determining the 
process of proteolytic activation of Hemagglutinin 1 by Tmprss2.Therefore 
producing Tmprss2 for crystallization is an essential step for structure-based 
drug design for Hemagglutinin 1. This thesis is specifically concerned with the 
cultivation of recombinant Pichia pastoris cell lines in 2 L scale using a 
bioreactor to demonstrate the potential of iterative methanol induction cultivation 
mode for Tmprss2 production. The initial hypothesis was that the production of 
Tmprss2 could be increased with optimized cultivation methods and 
NiSepharose™ Excel resin material could be utilized in optimizing direct 
immobilized metal ion affinity chromatography(IMAC) of Tmprss2. It is important 
to note that for IMAC fusing Tmprss2 with a histidine-tag is required, 
consequently recombinant expression is necessary for preforming IMAC. 
The iterative methanol induction cultivation mode has been previously used in 
Tmprss2 production in flask scale successfully. Based on previous studies 
advanced strategies for upscaling the iterative methanol induction cultivation 
mode to reactor scale were developed and tested to meet production goals for 
crystallization. The scope of the experiments was limited to developing 
optimized cultivation strategies for previously developed recombinant Pichia 
pastoris cell lines and exploring the potential of NiSepharose™ Excel resin 
material in immobilized metal ion affinity chromatography of Tmprss2. The 
previously developed cell lines used in this thesis work were “Tmrss2-Mut” (P. 
pastoris KM71H/pPICZα-Tmprss2-D343Nopt clone o108 MutS) and “Tmprss2-
WT” (P. pastoris Wild type jackpot clone KM71H-pPICZα-Tmprss2-WTopt o20). 
The research was carried out in five experimentation Cycles over the period of 
11 weeks in “Recombinant Protein Expression"-research group in Helmholtz-
Centre for Infection Research, Braunschweig, Germany. 
The outcome of this research into protein production and purification of type II 
transmembrane protease Tmprss2 in Pichia pastoris was a strategy for 
optimized cultivation of Pichia pastoris cell lines in 2 L scale using a bioreactor 
in iterative methanol induction cultivation mode. The initial hypothesis was also 
confirmed as NiSepharose™ Excel resin material could be utilized in direct 
immobilized metal ion affinity chromatography of Tmprss2 without issues with 
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column stripping common in similar IMAC materials designed for histidine 
tagged proteins. Tmprss2 was produced in the target amount for crystallization 
experiments in a single iteration using the Tmprss2-Mut cell line. However, the 
fast 48 h production Cycle in iterative methanol induction mode would allow 
pooling the produced Tmprss2 from several successive iterations to reach 
higher amounts. Pooling the products of several iterations would make reaching 
sufficient amounts for crystallization of the desired autocatalyzed form of 
Tmprss2 produced by the Tmprss2-WT possible. The issue with the lowered 
Hemagglutinin 1 cleaving activity of Tmprss2 D343N produced by the Tmprss2-
Mut expression cassette could potentially be countered by coincubation with 
processed Tmprss2 produced with the WT-Tmprss2 expression cassette. 
Autocatalyzing the uncleaved Tmprss2 D343N to process it to the truncated 
form with higher activity would reduce the amount of iterations required to reach 
ample amounts of active Tmprss2 for crystallization. 
The limitations of the developed upstreaming and downstreaming strategies 
were also recognized. The main issues encountered were loss of Tmprss2 in 
concentration and through degradation over time. The purification using IMAC 
was prone to issues with precipitation of the culture supernatant interfering with 
the process. The iterative methanol induction cultivation mode requires 
removing the cell culture from the reactor in between iterations causing 
increased risk of contamination. Further development for countering these 
limitations were suggested in the form of modified techniques. Loss of protein 
during concentration might be avoided using a more sophisticated concentration 
technique i.e. repeated IMAC, diafiltration or TCA precipitation. The degradation 
of Tmprss2 could be limited by conducting IMAC in 4 °C instead of room 
temperature. The precipitation problems may be addressed by monitoring and 
adjusting the concentration of media components throughout the cultivation to 
prevent building up of materials in successive iterations. Risk of contamination 
and degradation of Tmprss2 during cultivation could be decreased by 
implementing continuous cultivation with perfusion membrane for harvesting. 
The cultivation strategy could also be shifted from aiming to shorten the glycerol 
growth phase to aiming to run the reactor in ultra-high cell density conditions. 
Running the reactor in the range of OD> 500; WCW >400 g/L would be a trade-
off for increased Tmprss2 total yields at the cost of longer process time for a 
single batch of Tmprss2. The increased total yields could be reached by 
upscaling the reactor cultivation based on the methods developed for a 2 L 
scale bioreactor in iterative methanol induction cultivation mode.   
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Abbreviations and terms 
 
AF   Anti-foam, 5% (V/V) Struktol J 673 dissolved in methanol 
AOX1   Alcohol oxidase 1 promoter 
BMGY   Buffered minimal glycerol medium with yeast extract 
BMMY   Buffered minimal methanol medium with yeast extract 
GRAS   Generally recognized as safe 
Cycle 0 Tmprss2-WT in 2 L Erlenmeyer flasks in fed-batch 
cultivation mode 
Cycle 1 Tmprss2-WT in 2 L Erlenmeyer flasks in hybrid iterative 
methanol  
Cycle 2 Tmprss2-WT in 2 L Labfors 3 reactor in iterative methanol 
induction cultivation mode 
Cycle 3 Tmprss2-Mut in 2 L Labfors 3 reactor in iterative methanol 
induction cultivation mode  
Cycle 4 Tmprss2-WT in 2 L Erlenmeyer flasks in single batch 
cultivation mode 
GOI Gene of interest 
H1    Hemagglutinin 1 
HAT / DESC  human airway trypsin-like protease/differentially expressed 
   in squamous cell carcinoma subfamily 
HZI  Helmholtz-Centre for Infection Research, Braunschweig, 
Germany 
HPI    Hours post induction 
IMAC    Immobilized metal ion affinity chromatography 
in vitro In a controlled environment outside of a living organism in a 
reaction tube or bottle 
in vivo   In whole living organisms or cells 
kDa   Kilodalton 
Milli-Q water  Ultrapure water of Type 1 as defined in ISO 3696:1987 
9 
 
MWCO   Molecular weight cut-off 
OD595   Optical density at 595 nm wavelength 
PBS   Phosphate-buffered saline 
PCR   Polymerase chain reaction 
pO2    Dissolved oxygen 
P. pastoris  Pichia pastoris (Komagataella phaffii) 
rpm    Rounds per minute 
RT  Room temperature 23 °C on average 
SDS-PAGE  Sodium dodecyl sulphate polyacrylamide gel 
electrophoresis 
S1   Laboratory biosafety level one 
TEV protease  Tobacco Etch Virus nuclear-inclusion-a endopeptidase 
Tmprss2   Transmembrane protease, serine 2 
Tmprss2 D343N a form of Tmprss2 produced by Tmprss2-Mut. Mostly in the 
form of the full ectodomain in 45 kDa range 
Tmprss2-Mut  P. pastoris KM71H/pPICZα-Tmprss2-D343Nopt clone o108 
mutS-strain 
Tmprss2-WT  P. pastoris Wild type jackpot clone KM71H-pPICZα-
Tmprss2-WTopt o20 
TTSP   Type II transmembrane serine proteases  
UV   Ultraviolet 
WCW  Wet cell weight in grams of cells per 1 kg of culture (g/kg) 
WB    Western blot 
YPD    Yeast extract peptone dextrose 
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1 Introduction 
 
Influenza(H1) is an acute viral infection causing seasonal epidemics especially 
during wintertime. It is also the cause for several pandemics such as the 
Spanish Flu A H1N1 (1918-1919), Asian Flu A H2N2 (1956-1958), Hong Kong 
Flu A H3N2 (1968-1969) and A H1N1/09 Flu Pandemic (2009–2010). 
Influenza is mostly non-life-threatening however, it is a general burden to public 
health and may cause complications leading to death especially in children, the 
elderly and people with already weakened immune systems. Influenza virus is 
classified into three genera A, B and C. Originally an avian virus the influenza 
virus A as can be seen from the list of pandemics is commonly the genus 
causing pandemics while mammalian viruses B and C cause epidemics on a 
yearly basis. Bacterial antibiotics are not effective in treating influenza as it is a 
viral infection (1,2,3).  
Instead treatment approaches target neuraminidase and M2 viral proteins 
involved in replication of the influenza virus. The high mutation rate of H1 is 
observed to develop resistance to anti-viral drugs hindering their effectiveness. 
Anti-viral drugs targeting neuraminidase are currently not effective in treating 
influenza (1,2,4). 
Influenza remains a global health concern because of the annual influenza 
epidemics, the risk of a pandemic due to a new potent mutant and the lack of 
efficient treatment. 
Several reports speculate the transmembrane protease, serine 2 (Tmprss2) to 
be involved in the activation and subsequent replication of H1 (5,6,7,8). The link 
has been further studied and Tmprss2 has been found to be vital in the 
activation of H1 in living mice (9). The link between Tmprss2 and H1 infection 
was demonstrated again in Tmprss2 deficient mice, which were found to be less 
susceptible to get infected than WT mice (10, 19). Structural and functional 
analyses of crystallized Tmprss2 would be required in understanding both its 
physiological and H1 activation functions. The crystal structure of Tmprss2 and 
the enzyme-substrate interaction surface in combination with H1 could lead to 
determining the process of proteolytic activation of H1 by Tmprss2. This would 
require successful crystallization of active Tmprss2 with H1. 
Producing crystals of pure Tmprss2 would require minimum amount of 
approximately 2 mg of properly folded and active Tmprss2. Tmprss2 is a difficult 
to express protease because it’s produced in extremely low amounts and only 
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in optimized cell lines of P. pastoris  among several tested expression hosts. 
Comparably higher amounts are only reached in mutant D343N form with most 
of the produced tmprss2 secreted as its full ectodomain at a state with reduced 
activity with H1 (12). Difficult to express proteases expressed in a heterologous 
expression system may not be fully soluble, well-folded or in an active form 
especially when proteases of higher eukaryotes are produced by prokaryotes. 
Therefore, an expression system capable of preforming post-translational 
modifications resulting in functionally active forms because of mannose type N-
glycosylation close to higher eukaryotes and efficient protein folding is required. 
Komagataella phaffii previously assigned as Pichia pastoris is well known as 
one of the prominent expression systems in biotechnology (11). This 
methylotrophic yeast meets the mentioned requirements and is a fast growing 
and cost effective alternative to mammalian or insect cell cultures. 
Recombinase mediated cassette exchange Pichia pastoris master cell lines for 
producing the active WT form and mutant form D343N of Tmprss2 were also 
recently developed (12). 
This bachelor’s thesis work is focused on creating strategies for producing the 
difficult to express transmembrane serine protease mouse Tmprss2 in Pichia 
pastoris in sufficient amounts for crystallization experiments. 
Upstreaming as well as downstreaming strategies were developed for 
increasing the mutant (D344N)- and active Tmprss2 yields. Upstreaming 
strategies were optimized by cultivation of both Pichia pastoris cell lines in 2 L 
scale using a bioreactor in iterative methanol induction cultivation mode. 
Downstreaming was improved by testing the viability of NiSepharose™ Excel 
material for direct immobilized metal ion affinity chromatography of Tmprss2. 
 
1.1 The type II transmembrane serine protease Tmprss2 
Tmprss2 belongs in the family of type II transmembrane serine proteases 
(TTSP), which are expressed initially as single-chain proenzymes. TTSP family 
proteases require autocatalytic activation by the cleavage of their respective 
conserved zymogenic site (13). 
This family has four subfamilies the Matriptase subfamily, the HAT / DESC 
human airway trypsin-like protease/differentially expressed in squamous cell 
carcinoma subfamily, the Hepsin / Tmprss subfamily and finally the Corin 
subfamily. Tmprss2 belongs to the Hepsin / Tmprss subfamily which is 
differentiated from the other subfamilies by its serine protease domain and its 
domain structure (14, 15, 16, 17). Regardless of similarity to other proteases in 
its family Tmprss2 is the only one capable of cleaving H1HA in vivo (9). 
Tmprss2 can be found in a variety of truncated forms, most notably as the 
active serine protease domain by itself or as the full ectodomain (18). 
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Figure 1 Scheme of Tmprss2 construct; transmembrane domain (TM); low-density 
lipoprotein receptor class A domain (LDLA; a scavenger receptor cysteine-rich domain 
(SRCR); C-terminal serine protease domain (SPD). Image from (12)  
Tmprss2 as a transmembrane protease is composed of cytoplasmic, 
transmembrane and ectodomain. The cytoplasmic domain is composed of N-
terminal tail which is connected to the ectodomain by its transmembrane 
domain (TM). The extracellular domain comprises a low-density lipoprotein 
receptor class A domain (LDLA), a scavenger receptor cysteine-rich domain 
(SRCR) and the C-terminal serine protease domain (SPD). On Western blot the 
primary antibody used targets only the C-terminal fragment. Differentiation 
between the cleaved and unprocessed forms of Tmprss2 was still possible by 
the molecular weight of the two forms. The total ectodomain prior to 
autocatalytic cleavage at marked zymogen cleavage site in Figure 1 has a 
molecular weight of ~45 kDa. The C-terminal serine protease domain (SPD) 
itself post cleavage has a molecular weight of ~30 kDa. (12)  
 
Figure 2. Serine protease cleavage of H1; hemagglutinin H1 from its unprocessed form 
into two subdomains HA1 and HA2. Image from (12) 
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Tmprss2 has been speculated and observed to be involved in replication and 
activation of H1 as previously mentioned in 1 Introduction (5, 6, 7, 8, 9, 10, 19).   
Tmprss2-WT and the activity knockdown mutant Tmprss2-D343N have been 
shown in vitro to be able to perform cleavage of H1 as seen in Figure 2. The 
recombinant D343N expressed mostly as the total extracellular domain of 
Tmprss2 performs H1 cleavage at a slower rate and it has not been established 
if it needs to be autocatalytically processed before binding to H1. (12)  
Despite demonstrated activity with H1 the physiological function of Tmprss2 
remains unclear. The Tmprss2 deficient mice were healthy, showed no changes 
in their phenotype and had no change in the regulation of their other TTSPs to 
compensate the lack of Tmprss2 (20).   
 
1.2 Methylotrophic yeast Pichia pastoris 
Komagataella phaffii is a single-cell eukaryotic expression system frequently 
used to produce secreted eukaryotic proteins. Komagataella phaffii assigned as 
Pichia pastoris previously, was relatively recently reassigned as its own separate 
species. Multigene sequence analysis was used to differentiate K. pastoris, K. 
phaffii and K. pseudopastoris as separate species of P. pastoris. K. phaffii was 
identified as the Pichia pastoris strain which is commonly used in in gene 
expression utilizing the “Pichiapastoris Expression Kit” from Invitrogen 
Corporation (11). Because Pichia pastoris is still such a prominent name used 
in the field of biotechnology to refer to K. phaffii in this bachelor’s thesis work K. 
phaffii is also simply referred to as P. pastoris. 
Unlike prokaryotes, P. pastoris can perform post-translational modifications 
resulting in functionally active forms because of mannose type N-glycosylation 
close to higher eukaryotes and efficient protein folding. These attributes make it 
proficient in producing hard to express recombinant proteases such as Tmprss2 
(21). 
P. pastoris secretes only a few proteins into the culture medium. This leads to a 
situation where the excreted recombinant protease is the only protease in 
significant amounts in the supernatant (22).  It also has no tendency for 
hyperglycosylating proteins during posttranslational modification which leads to 
fewer problems with secretion and/or inactive forms. (23, 24, 12).  
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Figure 3.  Stable transformation of P. pastoris by homologous recombination. Image from 
(12). Expression cassette for the gene of interest (GOI) with Zeocin resistance is 
engineered for a recombinant producer cell line. The GOI, the AOX1 promoter “PAOX1” 
and a Zeocin resistance Zeo
R
 are in contained expression vector pPICZ-GOI. A uniquely 
cutting restriction enzyme marked as a pair of scissors on top left linearizes the vector 
inside “PAOX1”. The vector is inserted into the AOX1 genomic locus homologous to the 
targeting sequence on the vector by homologous recombination in the yeast nucleus 
(12). 
 
15 
 
 
Figure 4. Tmprss2 constructs schematics for recombinant expression in P. pastoris cell 
lines WT and Mut D343N. Image from (12) The protein is directed to the supernatant by N-
terminally fusing it with a mating factor α secretion signal (MF-α ss). For purification and 
detection, a Flag tag and an 8xHis tag are C-terminally fused to the protein. TEV protease 
site is located upstream of the tags. The function of TEV protease section is to cleave the 
tags off. Low-density lipoprotein receptor class A domain (LDLA) and a scavenger 
receptor cysteine-rich domain (SRCR) remain unaltered. Position 109 of the full protein: 
alignment of the translated recombinant construct sequences used in Tmprss2. Position 
235 of the full protein: D343N mutation amino acid replacement of the aspartic acid of the 
catalytic triad to asparagine. The catalytic triad amino acids are marked with blue arrows 
(12). 
The mutant strain of P. pastoris Tmprss2-Mut (Mut D343N in Figure 4.) used in 
this bachelor’s thesis work represents the Methanol Utilization Slow (Muts) 
phenotype. Muts strains are characterized by the deletion or disruption of their 
AOX1 gene as it is replaced by the expression cassette. Their growth on 
methanol as carbon source is slowed down as the Muts strains can only rely on 
the weaker AOX2 in alcohol oxidase for methanol utilization. The slower growth 
rate sets a requirement for tightly controlled methanol feed rate maintaining 0,2-
0,8% (V/V) methanol in reactor conditions. In comparison to Methanol Utilization 
Positive (Mut+) strains where both AOX1 and -2 promoters are intact this lower 
feed rate results in slower growth and target protein production, but also lowers 
the risk of accumulating formaldehyde ultimately resulting in loss of culture. In 
comparison Mut+ strains, Muts strains boast a slower, but less risky alternative 
capable of utilizing the strongly inducible AOX1 promoter for controlling 
expression. The third alternative Methanol Utilizating Negative Mut- strain 
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cannot utilize methanol for alcohol oxidase at all because they have both AOX1 
and -2 disruption. They are still capable of having their AOX1 promoter induced 
by methanol in low concentrations. Expression in Mut- strains is conducted with 
a mixed feed where glycerol is fed at a low rate which does not repress the 
AOX1 promoter being induced by a constant concentration of methanol which is 
only being fed to counter the amount lost through evaporation (28). 
P. pastoris was cultivated with several different methods throughout this 
bachelor’s thesis work. Regardless of the differences between methods some 
aspects of the cultivation process remain the same for all methods. The 
experiments for this thesis work could be carried out in S1 Laboratories as P. 
pastoris is classified to be a GRAS organism. In addition to being safe to work 
with the cultivation conditions can be described as mild and media components 
required are relatively cheap. Two main challenges in the cultivation process 
were the repeated handling of highly inflammable and cytotoxic methanol in 
quantities up to several litres as well as ensuring the sterility of P. pastoris 
cultures. As a single cell eukaryote, P. pastoris is a fast-growing organism and 
can be cultivated in high cell densities up to 500 OD595 in reactor conditions. 
This methylotroph is commonly grown in defined simple medium while being fed 
with carbon sources in phases. This stepwise cultivation strategy is made viable 
by the yeast carbon source hierarchy of preferably utilizing in descending order 
first glycerol, then ethanol, acetate and finally methanol. The hierarchical 
utilization of carbon sources enables very specific induction just by altering the 
carbon source feed.  
The phases consist of a glycerol growth phase with a main goal of rapidly 
generating biomass, while repressing the AOX1 promoter in the absence of 
methanol. After the initial amount of glycerol in medium has been consumed the 
glycerol growth phase is then continued with a fed phase. This fed phase can 
be used to generate further biomass or for feed limitation to prepare the cells for 
methanol induction. The cells can be prepared for induction phase through 
feeding either with a growth limiting rate of glycerol feed or with a mixed feed 
containing both methanol and glycerol. 
The glycerol growth phase allows reaching a desirable cell density without an 
increased risk of accumulating toxic amounts of metabolic products such as 
formaldehyde which is only produced in methanol phase. The risk of 
accumulating metabolic products occurring also in the glycerol phase such as 
ethanol are prevented further by the strong tendency of P. pastoris to 
physiologically favor respiratory rather than fermentative growth (21). 
Methanol induction phase is reached after glycerol and other intermediate 
AOX1 repressing carbon sources have been consumed. The AOX1 gene is 
induced only by methanol and methanol will serve as the single carbon source. 
The strongly inducible AOX1 promoter triggers the production of the 
recombinant protease Tmprss2 only in the presence of methanol. P. pastoris is 
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flexible in whether the protein is produced intra- or extracellularly, but in the 
experiments conducted for this thesis work both Tmprss2-WT and Tmprss2-Mut 
cell lines produced Tmprss2 extracellularly. During the methanol expression 
phase methanol is initially oxidized by AOX to formaldehyde and hydrogen 
peroxide, the accumulation of these toxic intermediate products can be 
hazardous to the culture. Especially in the transition phase from glycerol to 
methanol. Furthermore, accumulation of methanol itself from feed is possible if 
instead of it P. pastoris is consuming carbon sources higher in its carbon source 
hierarchy that may be present in the transition phase or in low oxygen 
conditions. Therefore, real time measurement and adjustment of methanol and 
dissolved oxygen levels in methanol expression phase are crucial to avoid loss 
of culture. (25) 
 
1.3  Flask cultivation  
It was necessary to run initial tests on cultivation strategies in flasks prior to 
reactor experiments. Even though theoretically the ability to closer monitor and 
regulate cultivation conditions in a bioreactor should lead to higher cell densities 
and yields of desired product, several experiments could be run simultaneously 
for comparison in flasks. This offered a clear advantage on assessing iterative 
methanol induction cultivation mode variations as the only available reactor 
would have required to have successive runs taking up twice the amount of time 
used for the same experiments in flasks.  
Figure 5. Cultivation phases of P. pastoris in flask cultivation. The glycerol growth phase 
resembles a single batch cultivation where all glycerol in the medium is consumed. In the 
harvest step the cells are separated from 5 L of BMGY-AF medium by centrifugation and 
resuspended in 1L of BMMY-AF medium effectively concentrating the culture 5:1. The 
methanol induction phase is a feed phase where the methanol level is replenished back 
up to 0.5% (V/V) every 24h to maintain induction. 
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Flask cultures were conducted in 1 L medium volume in baffled 2 L Erlenmeyer 
flasks placed in 28 °C Multitron incubation shaker at 130 rpm. The flasks were 
prone to producing a foam layer which was substantial enough to inhibit 
aeration. This issue was countered by addition of 5% (V/V) Struktol J 673 up to 
0,1% (V/V) of the total medium volume.  
Cultivation in flasks required concentrating cells 5:1 to reach higher OD for 
methanol induction phase. This was achieved by having a total of 5 L of 
preculture in BMGY distributed in five 2 L baffled Erlenmeyer flasks during 
glycerol phase and pooling the cells together by centrifugation and 
resuspending them in 1 L of BMMY for the methanol induction phase. 
BMGY-AF and BMMY-AF media prepared according manual for P. pastoris 
expression (27) were used for flask cultures in their respective phases unless 
stated otherwise. The growth of P. pastoris in flasks was monitored every 24h. 
OD measurement as well as measuring the wet cell weight(WCW) during cell 
harvesting, while Tmprss2 production could only be detected and measured at 
the end of each production Cycle . Throughout the thesis work several patterns 
of feeding and repeating batches as well as single batches were run to test 
potential optimization strategies of Tmprss2 production. These tests included 
testing for effects of gradual methanol feeding in the beginning of induction 
phase instead of raising the levels directly to target levels. Another variable 
tested was increasing the target methanol level from 0.5% to 1%. Flask 
cultivation modes experimented with in 2 L flasks were single batch, iterative 
methanol induction and hybrid iterative methanol induction. In the hybrid mode, 
the glycerol growth phase took place in a 2 L Infors Labfors 3 reactor and the 
methanol induction phase in 2 L flasks. 
 
 
1.4  Reactor cultivation  
Considering large scale production, the media and cultivation condition 
requirements of P. pastoris are economical and make it a potential candidate for 
reactor scale cultivation and upscaling. In reactor, the full technical setup also 
allows for continuous carbon source feeding and monitoring of key cultivation 
parameters. The closely monitored and controlled environment creates potential 
for higher product yields and cell densities compared to flask cultivation. 
Reaching high cell densities also creates a need for reoptimization of cultivation 
conditions, but an optimized small scale reactor process can be considered 
representative of requirements for upscaled processes with only minor 
modifications. (21) 
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Figure 6. Common cultivation phases of P. pastoris in reactor cultivation. The glycerol 
growth phase resembles a single batch cultivation where all glycerol in the medium is 
consumed. The glycerol feed phase has many variations for feeding and duration, but in 
this thesis, it was implemented for approximately 6h with the goal to accumulate more 
biomass with maximal feeding and enhanced aeration. The methanol induction phase is 
also a fed phase where the methanol level is kept constant with an automated system to 
maintain induction. 
 
Both Tmprss2-WT and -Tmprss2-Mut were cultivated in reactor only once 
during this bachelor thesis work, due to the limitation of available time. The 
cultivation strategy in reactor was based on hybrid cultivation tests conducted 
first in reactor for the glycerol feed phase and then divided into two cultures in 
flask cultivation mode for methanol induction phase. Iterative methanol 
induction cultivation mode was implemented in the same manner for both 
Tmprss2-WT and -Tmprss2-Mut for two iterations. This meant that each run 
(Cycle ) produced approximately 2,5 litres of supernatant in total while this 
supernatant was purified and analyzed in two separate batches. Because of the 
fast degradation rate of Tmprss2 at 72 HPI significant degradation of Tmprss2 
can already be recognized in the culture supernatant (12). The 48h length of 
methanol induction iteration was chosen to avoid extra loss of Tmprss2 as after 
harvest it still took 24h more to complete IMAC. 
The amount of time required for batches was further reduced by shortening the 
glycerol growth phase by adding pure oxygen into the reactor airflow during 
exponential growth phase. This eliminated restriction on glycerol feed rate due 
to lack of aeration as there was no longer a risk of causing the pO2 to decrease 
below desired 20% due to high metabolic rate during exponential growth.   
In both Tmprss2-WT and -Tmprss2-Mut reactor cultivations AF was added far 
beyond the need for its primary purpose due to over sensitivity of the AF 
sensor. This resulted in the high concentrations of AF Struktol J673A which 
seem to increase recombinant protein expression and secretion in P. pastoris 
(26). 
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1.5  Iterative methanol induction cultivation mode 
The common cultivation strategy divided in a glycerol and methanol phase 
leads to a process which is not producing Tmprss2 approximately half of the 
time. The glycerol phase serves only to produce biomass and Tmprss2 is only 
produced in methanol phase when AOX1 promoter is induced. When 
considering optimization of the process not only the peak production amounts 
should be considered, but also the time it takes to produce a batch of product. 
Iterative methanol induction can be used to cut down the time of production for 
consecutive batches by resuspending the already induced cells in fresh 
expression medium eliminating the need to repeat the glycerol growth phase. 
The expression can then be continued for another 48h producing an expression 
yield comparable to the first iteration in the second batch (12). 
 
In this thesis work this iterative methanol induction cultivation mode was 
upscaled from flasks to a 2L reactor setup. In reactor scale the various probes 
needed to stay submerged and thus only 2/3 of reactor volume could be 
harvested between iterations. This meant that in reactor the iterative methanol 
induction cultivation mode was conducted as a repeated fed batch, in which the 
cells harvested between iterations were suspended in fresh reactor media 
without glycerol equal to the amount of expression media that was harvested. 
This fresh media was then fed back into the reactor and mixed with the 1/3 of 
old expression media while the reactor system automatically regulated the 
methanol levels back to the desired level keeping the cells induced. 
While the fresh media and the feeds from the reactor cultivation setup provide 
everything required for maintaining the culture. In theory, the iterations could be 
repeated limitlessly without losing expression, creating a semi-continuous 
process. Increasing the successive amount of iterations only further increases 
the Tmprss2 production efficiency of the process as a whole, as the time 
required for the initial glycerol phases becomes a smaller fraction of the total 
process time with each iteration. 
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2 Aims 
 
2.1 Production of mouse Tmprss2 in Pichia pastoris in 
sufficient amounts for crystallization experiments. 
Production of Tmprss2 was measured qualitatively by mass-spectrometry, 
Western blot and SDS-PAGE to identify the product and its form. The produced 
amount of Tmprss2 was measured quantitively by spectrophotometry. The aim 
was to generate 2 mg amounts of mouse Tmprss2 in active form for 
crystallization experiments. 
 
2.2  Testing the viability of NiSepharose™ Excel material for 
direct immobilized metal ion affinity chromatography of 
Tmprss2. 
IMAC was conducted in self-packed Bio-Rad column with NiSepharose™ Excel 
material as well as a premade HisTrap™ excel 5 mL column to test the two 
available excel IMAC products available from GE Healtchcare GmBH. The 
success of IMAC was measured qualitatively by mass-spectrometry, Western 
blot and SDS-PAGE to determine whether Tmrss2 could be bound from the 
supernatant with this material. The amount of bound product was measured 
quantitively by spectrophotometry. The viability of the material was assessed in 
the terms of stripping of the immobilized nickel ions and the achieved Tmprss2 
binding compared to Ni-NTA His-Bind material. 
 
2.3  Development of strategies for optimized cultivation of 
Pichia pastoris cell lines in 2 L scale using a bioreactor in 
iterative methanol induction cultivation mode. 
The efficiency of the cultivation strategies was measured quantitively in time (h), 
OD and WCW to find the effect of the improvements. The efficiency of methanol 
induction strategies was measured through protein production.  
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3 Materials 
 
Materials used in this bachelor’s thesis can be found listed in 9.3 Appendix 3. 
Materials list. The chemicals and reagents used were of analytical grade and 
when in solutions dissolved in Milli-Q water unless stated otherwise. Water used 
in experiments and solutions was Milli-Q water or autoclaved Milli-Q water when 
required.  
All materials were provided by Helmholtz-Centre for Infection Research, 
Braunschweig, Germany and used in compliance with their requirements. All 
laboratory equipment was operated according to protocols provided by their 
respective manufacturers under parameters specified in individual topics in 
section 4. Methods. 
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4 Methods 
4.1 Process flowsheets 
 
Figure 7. Process flowsheet for Cycles 0, 1 and 2; 
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1. Conclusions:  Successful capture and concentration of Tmprss2 with NiSepharose
TM
 
excel see section 5.3.1 Cycle 0, Tmprss2-WT in 2 L Erlenmeyer flasks in fed-batch 
cultivation mode. Decision to upscale to 2 L Labfors 3 reactor and to perform IMAC with 
Histrap
TM
 excel 5 mL column using Äkta start in Cycle 1; 
2. Conclusions: Hardware failure of connector between methanol sensor and feed pump. 
Since Automatic methanol feeding was not possible the culture was transferred into 2 L 
Erlenmeyer flasks and tests on two iteration strategies A and B were performed see 
section 4.2.2 Flask cultivation method; 
3. Conclusions: Iteration strategy A appeared more promising based on OD results and 
was chosen for purification see section 5.1.1 Cycle 1 optical density 595, Tmprss2-WT in 
2 L Erlenmeyer flasks in hybrid iterative methanol induction cultivation modes A & B. 
IMAC with Histrap
TM
 excel 5mL column using Äkta start was also shown to be successful 
see section 5.2 Protein production results and section 5.3.2 Cycle 1, Tmprss2-WT in 2 L 
Erlenmeyer flasks in hybrid iterative methanol induction cultivation mode. Tmprss2 band 
from C1.1 SDS-PAGE see Figure 23. was sent for mass spectrometry and confirmed to be 
Tmprss2 see 5.4.1 Cycle 1.1 concentrated total fraction;  
4. Conclusions: Method for iterative methanol induction cultivation mode in 2 L Labfors 3 
reactor was devised based on Iteration method A see section 4.2.3 Reactor cultivation 
method. 
5. Conclusions: loss of expression or the produced Tmprss2 in reactor scale. Regarding 
cell mass and OD the method for iterative methanol induction cultivation mode was 
shown to be viable see section 5.1.2 Cycle 2 optical density 595 in methanol induction 
phase and was implemented also in Cycle 3. Cell line used in Cycles 0-2 was confirmed 
by C. Schinkowski at HZI to be Tmprss2-WT by PCR from the Cycle 2. precultivation 
sample. 
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Figure 8. Process flowsheet for Cycles 3 and 4; 
1. Conclusions: Successful IMAC, dialysis and concentration of 1. Iteration and 2. 
Iteration. Suspected contaminant protein band on lane 10 from Cycle 3.2 SDS page also 
seen on WB see Figure 27. was sent to mass spectrometry and confirmed not to be 
Tmprss2, but a cell wall protein from P. pastoris see 5.4.2 Cycle 3.1 Supernatant post 
IMAC. The unstable nature of Tmprss 2 and potential of autocatalytic processing of 
D343N Tmprss2 form by WT-Tmprss2 was recognized see Figure 30.. Cell line confirmed 
by C. Schinkowski at HZI to be Tmprss2-Mut by PCR from a Cycle 3 precultivation 
sample;  
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2. Conclusions: Anomaly in reactor detected see Figure 34, which led to suspicion of 
contamination. Microscopy preformed on a reactor culture sample, but only P. pastoris 
cells detected. Reactor sample was plated and unknown bacterial contamination 
detected. Cultivation was aborted in accordance with safety requirements. Due to time 
limitation, there was no time for more reactor runs and a decision was made to make a 
flask cultivation of Tmprss2-Mut in Cycle 4.;  
3. Conclusions: Major loss of Tmprss2 in concentration step was recognized see 5.2 
Protein production results. 
 
4.2 Cultivation methods 
 
4.2.1 Preculture cultivation method 
Cell line stock from -80°C storage was plated on YPD-plates by dilution 
streaking using an inoculation loop and incubated in 30°C for 48h to produce 
single colonies from the stock.  
One of these single colonies from the first plate is then replated in the same 
manner and incubated in 30°C for 48h to produce multiple single colonies. The 
YPD-plate is then stored in 4°C to preserve the colonies for use in inoculations. 
One of the storage single colonies was used per preculture to inoculate 200 mL 
of BMGY in 1 L baffled Erlenmeyer flask. The Erlenmeyer flask was then placed 
at constant 28°C in a shaking incubator at 130 rpm for 48h. The OD of the 
preculture was measured and the inoculation volume for reaching the required 
target inoculation OD of 1 was calculated.  
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4.2.2 Flask cultivation method 
 
Figure 10. flasks before (top left) and after (bottom left) glycerol growth phase without 
AF; flask with AF in methanol induction phase (right). 
 
In a standard fed batch flask cultivation also referred to as method A for hybrid 
cultivation, there were two phases. First a 48h glycerol growth phase in BMGY 
followed by a 48h expression phase in BMMY. The cultivation conditions for 
both were constant 28°C at 130 rpm in a shaking incubator. Sampling from the 
flasks as well as OD measurement was carried out every 24h as described in 
the methods sections 4.4.1 and 4.4.3 for these tasks. The glycerol phase was 
conducted in 5 baffled 2 L Erlenmeyer flasks. Each flask was filled with 1 L of 
BMGY-AF and inoculated to a starting OD of 1 from a fresh preculture. After 
48h at the end of the glycerol feed phase the cells from each flask were 
harvested by centrifugation in 1 L sterile centrifuge bottles as described in the 
methods section 4.3.1. These cells were then resuspended in 1 L of BMMY-AF 
and transferred in to a baffled 2 L Erlenmeyer flask that was the placed back in 
the shaking incubator. Halfway through the expression phase at 24h 5mL of 
100% methanol was fed in to the flask to raise methanol concentration back to 
0.5%(V/V ).  After another 48h the end of expression phase was reached and 
the supernatant was harvested while the cells were discarded or were used for 
iterative batches. In hybrid cultivation during Cycle 1 the iterations were 72h 
instead of 48h to better follow the growth in method B. In method B only half of 
the culture volume was harvested and the culture was replenished back up to 
its original volume with only fresh BMMY-AF without returning the harvested 
cells into the flask. 
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4.2.3 Reactor cultivation method 
Figure 11. Reactor setup for 2 L Labfors 3 reactor in methanol induction phase. 
Figure 12. Schematic overview of reactor setup for 2 L Labfors 3 reactor;  
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1. PC for data collection running Iris software; 
2. 0,5 L Schott flask of 5% (V/V) Struktol J 673; 
3. 0,5 L Schott flask of 12.5% ammonium for pH adjustment; 
4. 1 L Schott flask of either methanol or glycerol feed depending on cultivation phase; 
5.  Sartorius analytic BP 3100 S balance for monitoring feed weight; 
6. Sample collection outlet; 
7. Sample collection point;  
8. Raven biotech Inc. methanol sensor with separate air flow from the rest of the reactor; 
9. Overhead stirrer with 12 blades; 
10. Gas inlet inside the reactor;  
11. Mettler Toledo pH probe;  
12. Mettler Toledo pO2 probe; 
13. Infors temperature probe; 
14. Exhaust gas outlet in 1 L Schott flask submerged in 1M sodium hydroxide; 
15. 1 L Schott flask for transferring media components and inoculum in reactor during 
filling phase;  
16. Stainless steel baffle; 
17. AF probe and inlet port; 
18. Water cooled cooler for exhaust gas;  
19. Motor for stirrer 400 V; 
“Control unit” Central control unit for Labfors 3 reactor; 
“Air Source” Dry instrument air from central HZI system;  
“Nitrogen Source” Dry nitrogen gas from central HZI system; 
“Oxygen Source” Dry oxygen gas from central HZI system; 
“Cooling Circulator” Julabo F34 set to 4°C automatically circulating cooling water to 
keep reactor at 28°C based on temperature probe signal and keeping exhaust gas cooler 
at 4°C; 
“AF Pump” Standard Infors pump belonging to Labfors 3 reactor system, automated 
pumping based on AF sensor signal; 
“Base Pump” Standard Infors pump belonging to Labfors 3 reactor system, automated 
pumping based on pH sensor signal; 
“Feed Pump” model 101U from Watson Marlow Fluid Technology Group. Feed pump is 
only controlled automatically by the methanol sensor during methanol feeding and is set 
manually for glycerol feeding; 
“Air Filter” Pall Gelman Acrodisc CR PTFE with 0.2 μm pore size from Sigma-Aldrich Co.  
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The reactor setup and media were based on the methods outlined in the book 
Pichia protocols (28) and the manual for 2 L cultivation in Labfors 3 reactor from 
Infors. The method for two iterations in a 2 L Infors Labfors 3 reactor in the 
iterative methanol induction cultivation mode could be implemented also for 
more successive iterations, but describing more than two would be redundant. 
Several steps for the first and second iterations had to take place 
simultaneously to ensure minimal stress, risk of contamination and time outside 
of the reactor for harvested cells. 
Step 1. Preculture for reactor cultivation was prepared as outlined in section 
4.2.1 Preculture cultivation method. Media, feeds and additives for controlling 
the cultivation conditions for the initial run and following iterations were 
prepared. Calibration liquids of pH 7 and 4 were used for calibrating the pH 
probe.  Reactor was assembled and filled with base fraction of reactor media. 
Step 2. The reactor containing reactor medium without hexametaphosphate 
fraction, glycerol feed and reactor medium without hexametaphosphate or 
glycerol for subsequent iteration steps were autoclaved. 
Step 3 The reactor was assembled and the reactor run data collection started. 
Hexametaphosphate fraction of medium was added into the reactor. Stirring of 
the reactor was started. 
Step 4. The reactor pH was adjusted to 6 with 12.5% ammonium through the 
reactor base feeding system. Reactor temperature was set to 28°C and 
temperature control with the cooling circulator started. 
Step 5. The dissolved oxygen probe was calibrated by maintaining a 4 L/min 
flow of nitrogen and 1000 rpm stirring speed until the pO2 value stabilized. This 
stabilized value was then set as 0% pO2 reference value. The 100% pO2 
reference value was set by repeating the same process with air instead of 
nitrogen. 4 L/min flow of air was maintained as standard flow throughout the 
reactor run unless stated otherwise. Stirring speed was adjusted accordingly to 
maintain minimum 20% pO2 and when only stirring with standard flow was not 
enough pure oxygen was added into the airflow. AF regulation was already 
started by the reactor adding some AF in the reactor medium to prevent 
complications from stirring speeds up to 1000 rpm as well as fill volume close to 
the reactor maximum due to feeding later in the process. 
Step 6. OD of preculture was measured and inoculation volume for reaching 
inoculation OD of 1 was calculated. Test culture in reactor inoculated from the 
second preculture through the assigned port. Sampling and OD measurement 
were conducted as described in sections 4.4.2 Reactor sampling and 4.4.3 OD 
measurement. 
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Step 7. Glycerol growth phase was started by cultivating P. pastoris overnight in 
the reactor.  
Step 8. The p02 was decreased close to 0% by the overnight cultivation. Stirring 
speed was increased and/or additional oxygen was introduced into the air flow 
to raise pO2 above 20%.   
Step 9. Sampling and OD measurement were conducted. 
Step 10. Depletion of glycerol in the initial reactor media was observed as an 
p02 spike as P. pastoris ceased metabolizing it. 
Step 11. Glycerol feed phase was started. Glycerol feeding rate was slowly 
increased along with the amount of additional oxygen in the air flow to achieve 
maximal feeding rate while keeping pO2 above 20%. Glycerol feed phase was 
maintained for 5-6h.  
Step 12. Sampling and OD measurement were conducted. The desirable OD in 
reactor for glycerol ending feed phase was OD>120. When this target was 
reached, glycerol feeding was stopped.   
Step 13. Methanol probe was calibrated by adding methanol feed slowly up to 
0.5%(V/V) of the reactor volume in steps of 1-2%. The methanol sensor reading 
could stabilize in between the addition steps. Once a stable value for 0.5% was 
reached it was set as the set point for methanol feeding and the feed pump was 
set to automatic mode. This meant that as soon as the methanol concentration 
was detected by the methanol sensor to be below the set value it caused the 
feed pump to pump methanol feed into the reactor until the set point was 
reached. The calibration of the methanol probe and adding of methanol into the 
reactor also served as the transition phase into methanol induction marking the 
0 HPI. 
Step 14. After 24 HPI of the first 48h methanol induction iteration was started 
sampling and OD measurement were conducted as described in sections 4.4.2 
Reactor sampling and 4.4.3 OD measurement. The sampling and OD 
measurement were repeated after 6h. 
Step 15. After 48 HPI at the end of the first iteration. The reactor culture was 
sampled and OD was measured once again. 
Step 16. 2/3 of reactor volume was harvested through the sampling port directly 
into 1L centrifuge bottles. The harvested fraction was purified as described in 
the section 4.2 Purification. 
Step 17. The cells for first iteration were resuspended in an amount of reactor 
media without glycerol equal to the volume of culture that was harvested. This 
resuspended culture was then fed back into the reactor and the resulting 
mixture was sampled and its OD measured. 
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Step 18. Second iteration was carried out by repeating steps 14.- 16. with the 
exception of harvesting the full volume of the reactor in step 16.. 
Step 19. The cells from the final harvest were resuspended in water and 
autoclaved along with the reactor at the end of the cultivation process. 
 
4.3 Purification methods 
 
4.3.1 Centrifugation in harvesting phase 
All centrifuging steps were carried out with a Sorvall RC 6+ centrifuge, but 
different rotors and centrifuge bottles were required for different centrifugation 
steps. Initially empty weights of 1 L and 500 mL centrifuge bottles as well as 
their lids were measured. 1 L centrifuge bottles were filled with media to similar 
weight with maximal difference of 0.02 g. Total weight of filled flasks was 
measured and recorded. The bottles were weighed after pouring out the 
supernatant to measure the weight of flasks containing the wet cell pellet from 
the previous centrifugation step between each round of centrifugation. This data 
along with the weight of filled flasks and empty weights of the bottles could then 
be used to calculate WCW. In first round of centrifugation cells were separated 
from supernatant by centrifuging at 6000 g for 10 min in 4 °C. The first 
centrifugation round at 6000 g was then repeated with a second set of fresh 1 L 
centrifuge bottles which were weighed and balanced just as the first set was. 
Resulting supernatant from the repeated first centrifugation round was poured 
into 500 mL centrifuge bottles, which were then weighed and balanced in the 
same manner as 1 L bottles in the previous step. The 500mL centrifuge bottles 
were centrifuged at 24500 g for 30 min at 4°C. The second centrifugation round 
at 24500 g was then repeated with a second set of fresh 500mL centrifuge 
bottles which were weighed and balanced just as the first set was. Resulting 
supernatant from the repeated second centrifugation round was then ready for 
filtration. 
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4.3.2 Filtration 
 
Figure 13. Setup for vacuum filtration with 2 NALGENE Reusable bottle top filter units. 
Vacuum filtration 
Prefiltration of culture supernatant was required before sterile filtration because 
without prefiltration approximately 10 Sartolab P20 pressure filtration units 
would have been required per litre of supernatant due to constant clogging up of 
the 0.2 μm pore size filters. After prefiltration by vacuum filtration only 1-2 
Sartolab P20 pressure filtration units were used per sterile filtration of 1 L 
culture supernatant. Vacuum filtration was performed by simultaneously running 
2 NALGENE Reusable bottle top filter units connected to 2 Schott flasks of 1 L 
each. Approximately 100mL of culture supernatant could be filtrated in vacuum 
filtration per 0.45 μm Cellulose Acetate Filter from Sartorius Stedim Biotech 
Gmbh. Laboport series vacuum pump from KNF Neuberger Inc. was sufficient 
to create a vacuum for both filtration units. The vacuum filtration was preformed 
inside a Labcontrol fume hood from HESCO. Two units were used to half the 
time the culture supernatant had to be exposed to room temperature. The room 
temperature exposure was avoided to prevent Tmprss2 degradation. 
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Figure 14. Setup for sterile filtration with Sartolab P20 pressure filtration units. 
Sterile filtration 
All media stock solutions for media components that were heat sensitive and 
could not be autoclaved were sterile filtrated prior to use. Culture supernatant 
was also sterile filtrated before IMAC to prevent microbial growth and remove 
leftover debris. Sartolab P20 pressure filtration units with 0.2 μm pore size were 
used for sterile filtration. 
The material being filtrated was pumped using a Masterflex easy load L/S pump 
from Cole-Parmer Instrument Company through the filtration unit into a sterile 
Schott flask inside HERAsafe KS Biological Safety Cabinet from Thermo Fisher 
Scientific Inc.. The tubing for pumping was flushed with first with 100 mL 40% 
(V/V) ethanol followed by 200mL of Milli-Q water before and after filtration. 
Supernatant from cultivations was filtrated at 20 mL/min flowrate. Buffer 
solutions and media components were filtrated at 70 mL/min flowrate.  
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4.3.3 Immobilized metal ion affinity chromatography (IMAC) 
 
Figure 14. Setup for Cycle 0 IMAC being washed with Milli-Q water. 
IMAC in Cycle 0 was performed using separate hand packed Bio-Rad columns 
of 6mL NiSepharose™excel and Ni-NTA His-Bind. Model 101U pump from 
Watson Marlow was used for pumping at 3 ml/min rate during loading and 
elution phases. This gave both the culture supernatant and elution buffers 2-
minute residence time in the columns. The peak elution concentrations were 
identified by UV-absorption peaks using a Bio-Rad Laboratories Econo UV-
Monitor. The complete peak fractions of 9-16 mL were then directly collected 
into 50 mL Corning® centrifuge tubes. Ni-NTA His-Bind required addition of Ni-
ions directly into the culture supernatant prior to IMAC to prevent the column 
from getting completely stripped during loading. The nickel was added in the 
form of nickel sulphate up to 1 mM of the culture supernatant. 
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Figure 15. setup for IMAC with Äkta start in loading phase. 
In Cycles 1-4 only NiSepharose™excel material was used in the form of 
HisTrap™ excel 5mL prepacked column. The same column was used for all 
four cycles and cleaned per manufacturer instructions in between. Äkta start 
with automatic fractionation was used instead of the rudimentary setup in Cycle 
0. Although peak fractions were still identified through UV-absorption also 
parameters like conductivity and pressure could be observed. Peak fractions 
were collected in 2mL fractions into glass test tubes using the automatic 
fractionation function of Äkta start. The exact parameters of the IMAC captures 
for Cycles 1-4 Can be seen in 9.2 Appendix 2. Äkta start IMAC logs. 
 
4.3.4 Dialysis 
Dialysis was performed in PBS using dry Spectra/PorTM dialysis tubes with a MWCO of 
6000- 8000 kDa. The tubes were prepared for use by first saturating them in PBS 
buffer, this made them elastic and thus reduced the risk of the tubes being ripped 
during pipetting or by clamps used to seal the tube.  
Fractions that had been identified by spectrophotometry and or WB to contain Tmprss2 
were pooled together into the dialysis tube by pipetting.  
Dialysis was performed overnight at 4 °C in 2 L of PBS in a 2L beaker. The PBS 
solution was continuously stirred with a magnetic stirrer at 100-200rpm. 
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4.3.5 Concentration 
Heraeus MULTIFUGE 35-s from Thermo Fisher Scientific Inc. was used for 
centrifuging in all concentration processes at 3000-4000g depending on the 
cycle. Vivaspin tubes of varying sizes and with different MWCO were used for 
concentration in different cycles. All concentration steps were performed at 4°C.  
 
Table 1. Cycle 0 concentration parameters  
Cycle 0, 200mM imidazole buffer elution fraction from NiSepharose™excel 
capture Value 
Variant of Vivaspin tubes:  10 mL 
MWCO:  30 kDA 
Centrifugal force: 4 000 x g 
Starting volume:  10 mL 
Final volume: 0,5 mL 
Concentration ratio:  20:1 
Cycle 0, 500mM imidazole buffer elution fraction from NiSepharose™excel 
capture Value 
Variant of Vivaspin tubes:  10 mL 
MWCO:  30 kDa 
Centrifugal force: 4 000 x g 
Starting volume:  16 mL 
Final volume: 0,5 mL 
Concentration ratio:  32:1 
Cycle 0, 200mM imidazole buffer elution fraction from Ni-NTA His-Bind capture. Value 
Variant of Vivaspin tubes:  10 mL 
MWCO:  30 kDa 
Centrifugal force: 4 000 x g 
Starting volume:  11 mL 
Final volume: 0,5 mL 
Concentration ratio:  22:1 
Cycle 0, 500mM imidazole buffer elution fraction from Ni-NTA His-Bind capture. Value 
Variant of Vivaspin tubes:  10 mL 
MWCO:  30 kDa 
Centrifugal force: 4 000 x g 
Starting volume:  16 mL 
Final volume: 0,5 mL 
Concentration ratio:  32:1 
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Table 2. Cycle 1-4 concentration parameters 
Sample 
Variant of 
Vivaspin tubes 
(mL) 
MWCO 
(kDa) 
Centrifugal 
force (x g)  
Starting 
volume 
(mL) 
Final 
volume 
(mL) 
Concentration 
ratio 
Cycle 
1.1 2 10 3 000 8 0,1 80:1 
Cycle 
1.2 2 10 3 000 12 0,1 120:1 
Cycle 
2.1 N/A N/A N/A N/A N/A N/A 
Cycle 
2.2 N/A N/A N/A N/A N/A N/A 
Cycle 
3.1 2 5 3 000 8 1 8:1 
Cycle 
3.2 2 5 3 000 12 1 12:1 
Cycle 4 2 5 3 000 10 1 10:1 
 
 
4.4 Analytical methods 
 
4.4.1 Sampling 2 L flasks 
Sampling is conducted in HERAsafe KS Biological Safety Cabinet from Thermo 
Fisher Scientific Inc. using sterile plastic pipette tips. From each flask two 
samples are taken one for OD and one for storage. For each sample 1 mL is 
pipetted into a 1,5mL reaction cap. The OD sample is directly used for 
measurement. The sample for storage is first centrifuged with a Thermo 
Scientific Heraeus Fresco 17 centrifuge at 15 000 g for 10 minutes at 4°C. The 
liquid fraction is pipetted into another reaction cap while the pellet is preserved 
in the other. Both caps are then flash frozen with liquid nitrogen and stored in -
20°C. 
 
4.4.2 Reactor sampling 
Sampling from the reactor always happens through the designated sampling 
port. By closing the air exhaust the incoming airflow creates pressure in the 
reactor. This pressure then pushes contents of the reactor out through the 
sampling port. First a waste sample is taken to flush the tubing of the sampling 
port, thereafter the actual sample is taken into a Corning® 15 mL centrifuge 
tube. From this sample a separate storage sample is taken by pipetting 1mL 
into a 1,5mL reaction cap while the rest can be used for OD measurement. The 
storage sample is centrifuged at 15000 g for 10 minutes. The liquid fraction is 
pipetted into another reaction cap while the pellet is preserved in the other. Both 
caps are then frozen with liquid nitrogen and stored in -20°C. 
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4.4.3 Optical density 595 measurement 
Fresh media of the corresponding type was used as blank for dilutions lower 
than 1:100, water was used for higher dilution ratios. The higher dilutions for 
example 1:1000 were conducted in dilution series in 10mL volume using 
Corning® 15 mL centrifuge tubes and vortexed between dilution steps. 1 mL 
disposable cuvettes were used for both samples and blanks. WPA CO 8000 
Biowave Cell Density Meter set for 595 nm wavelength was used per 
manufacturer protocol for all OD measurements. Photometric Accuracy +/- 
0.02A at 1A. Photometric Range -0.3 to 1.99A. 
 
4.4.4 Electrophoresis 
Most equipment for electrophoresis was from Bio-Rad and was operated in accordance 
with the methods supplied by the manufacturer. The buffer solutions were not premade 
but prepared at HZI laboratories per Bio-Rad recipes. 
SDS-PAGE 
Gel: 12% 10-well Bio-Rad Laboratories Mini-PROTEAN precast gel 
Load amount: 20 μL 
Sample: 15 μL 
4xLoading buffer: 5 μL 
Voltage: 140 V 
Runtime :1h 
Marker protein: Precision Plus Protein™ All Blue Prestained Protein 
Coomassie staining solution for protein gels: Instant Blue  
 
Western blot 
Trans-Blot® Turbo™ Transfer System 
Turbo mode Mini gels: 25 V/1,3A, 7 min, used for Cycles 0, 1. and 2. 
Mixed mode Mini gels: 25 V/1,3A, 5 min, used for Cycles 3. and 4. 
Membrane: Immobilon-P polyvinylidene difluoride (PVDF) from Merck 
Primary anti-body: Mouse α-Flag    
Secondary anti-body: Anti-Mouse lgG (H+L), Ap Conjugate  
Colour Development Substrate: BCIP/NBT  
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4.4.5 Spectrophotometry 
NanoDrop 2000/2000c Spectrophotometer from Thermo Fisher Scientific was 
used for measurements per instructions provided in NanoDrop 2000/2000c V1.0 
User Manual by the manufacturer. 
 
Parameters for measurement: 
Mode: Purified BSA pedestal 
Sample size: 1 µL 
Sample type: A280 
Lower detection limit: 0.10 mg/mL 
Upper detection limit: 400 mg/mL 
Typical error: 0.10 - 10 mg/mL: + 0.10mg/mL; >10mg/mL: + 2% 
 
4.4.6 Mass spectrometry 
Mass spectrometry was performed by the research group Cellular Proteomics 
(CPRO) in HZI. The type of mass spectrometry used was MALDI-TOF (Matrix 
Assisted Laser Desorption Ionization – Time-Of-Flight). Sample bands were cut 
out from dried SDS-PAGE gels with a scalpel and stored in 1.5 mL Eppendorf 
tubes in 4°C prior to mass spectrometry. 
 
 
4.5 Sterilization and preservation methods 
 
4.5.1 Sterilization 
The Labfors 3 reactor was autoclaved at 2 Bar at minimum 121°C for 75 
minutes. 
Non-heat sensitive stock solutions were sterilized by autoclaving at 2 Bar at 
minimum 121°C for 20 minutes. 
Sterile filtration of media stock solutions which were heat sensitive as well as 
culture supernatant is described in section 4.3.2 Filtration. 
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4.5.2 Preservation 
Filtrated culture supernatant was preserved by adding 0,1% (V/V) Sodium azide 
to prevent microbial growth. The produced Tmprss2 in the supernatant was 
preserved with cOmplete Mini, EDTA free Protease inhibitor cocktail tablets 
from Roche Diagnostics GmbH. 1 tablet was used per batch of produced 
supernatant which were in the range of 500 – 1400 ml.   
Shock freezing by submerging liquid nitrogen was used to preserve cell and 
supernatant samples. 
Cold storage devices for storage options in 4°C, -20°C and -80°C are listed in 
the materials list. -80°C storage was only used for master cell lines of Tmprss2-
WT and Tmprss2-Mut while -20°C was used for flash frozen cell and 
supernatant samples. Stock solutions and samples that did not contain active 
cells could be stored in 4°C. 
All cold storage devices were connected to HZI backup power supply system 
and would continue to operate on generator power during a power outage. 
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5 Results 
 
5.1  Optical density 595 measurement results 
5.1.1  Cycle 1 optical density 595, Tmprss2-WT in 2 L Erlenmeyer 
flasks in hybrid iterative methanol induction cultivation modes 
A & B 
 
Figure 16. OD595 of iteration methods A and B over time; in method A full culture volume 
was harvested every 72h and the cultivation continued by resuspending the cells in fresh 
BBMY; in method B only half of the culture volume was harvested every 72h and the 
culture was replenished back up to its original volume with only fresh BMMY without 
returning the harvested cells into the flask. 
 
Based on the growth kinetics for 3 iterations seen in Figure 16. the iteration 
method A was chosen as the more potential method. P. pastoris cultivated with 
method B could not regenerate its cell density between harvests at 72, 144 and 
216 HPI. The A method showed no signs of decreasing cell density due to extra 
stress from three iterations. 
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5.1.2 Cycle 2 optical density 595 in methanol induction phase 
 
Figure 17. Cycle 2 OD595 over time in relation to methanol feed in methanol induction 
phase, Tmprss2-WT in 2 L Labfors 3 reactor in iterative methanol induction cultivation 
mode 
As can be seen the Tmprss2-WT in reactor cultivation appears to continue 
growth after iteration although there is a short lag phase. Unlike the growth 
curve for method A in Figure 16 the curve in Figure 17 doesn’t enter stagnation, 
but reached OD595 of 350 during two iterations. Instead of merely maintaining 
the reached cell density the Tmprss2-WT keeps growing in iterative methanol 
cultivation mode. The reason this was not observed in flasks is likely limitation 
by the methanol feed. In reactor Tmprss2-WT had automated constant 
methanol feed allowing it to continue growing even in higher OD. 
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5.1.3 Cycle 3 optical density 595 in relation to methanol feed, 
Tmprss2-Mut in 2 L Labfors 3 reactor in iterative methanol 
induction cultivation mode 
 
Figure 18. Cycle 3 OD595 over time in relation to methanol feed in methanol induction 
phase, Tmprss2-Mut in 2 L Labfors 3 reactor in iterative methanol induction cultivation 
mode. 
When comparing figures 17. and 18. clear differences between growth kinetics 
can be observed. Tmprss2-WT continues growth while the Tmprss2-Mut 
stagnates while still consuming methanol at a similar rate ro Tmprss2-WT. This 
could possibly be explained by the Tmprss2-Mut being a Muts strain. Similar 
behaviour in iterative methanol induction by the same cell line was seen in (12). 
 
5.2 Wet cell weight measurement results 
 
Figure 19. WCW in Cycles 2.1, 2.2, 3.1, 3.1 and 4 calculated from the cell pellet and 
medium weights from harvesting step. 
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The values in Figure 19 show no considerable reduction in WCW between 
iterations for either of the reactor runs in Cycle 2 or Cycle 3. The WCW for 
Cycle 4 being comparable with those for Cycles 2 and 3 demonstrates the 
comparability of flask and reactor experiments in these cell densities.   
 
5.2 Protein production results 
Table 3. Results for Tmprss2 production by P. pastoris measured with 
spectrophotometry. Values in parenthesis were consistently measured, but below the 
lower detection limit defined by the manufacturer. 
Cycle  Sample 
Calculated 
Tmprss2 yield 
(mg) 
Tmprss2 concentration 
(mg/ml) Blank 
C0 
20:1 Concentrated 200mM 
imidazole buffer elution 
fraction from 
NiSepharose™excel 
capture 0,08 0,16 
200 mM 
imidazole 
buffer 
C0 
32:1 Concentrated 500mM 
imidazole buffer elution 
fraction from 
NiSepharose™excel 
capture N/A 
Below lower detection 
limit  
500 mM 
imidazole 
buffer 
C0 
22:1 Concentrated 200mM 
imidazole buffer elution 
fraction from Ni-NTA His-
Bind capture N/A (0,05) 
Below lower detection 
limit (0,09) 
200 mM 
imidazole 
buffer 
C0 
32:1 Concentrated 500mM 
imidazole buffer elution 
fraction from Ni-NTA His-
Bind capture N/A 
Below lower detection 
limit  
500 mM 
imidazole 
buffer 
C1.1 
80:1 concentrated total 
fraction 
 
N/A (0,04) 
Below lower detection 
limit (0,09) 
200 mM 
imidazole 
buffer 
C1.2 
120:1 concentrated total 
fraction N/A 
Below lower detection 
limit  
200 mM 
imidazole 
buffer 
C2.1 First iteration total fraction N/A 
Below lower detection 
limit  N/A 
C2.2 
Second iteration total 
fraction N/A 
Below lower detection 
limit  N/A 
C3.1 
8:1concentrated first 
iteration dialyzed total 
fraction 1,42 1,42 PBS 
C3.2 
8:1 concentrated second 
iteration dialyzed total 
fraction 1,95 1,95 PBS 
C4 
unconcentrated dialyzed 
total fraction 4,78 0,48 PBS 
C4 
10:1 concentrated dialyzed 
total fraction 0,96 0,96 PBS 
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The protein production varied greatly between different Cycles and in general 
Tmprss2-Mut appeared to produce more Tmprss2 than the WT P. pastoris as 
was already observed by C. Schinkowski in (12).  In previous experiments 0.8 
mg/L yields of Tmprss2 D343N was achieved by Tmprss2-Mut and 80 µg/L of 
Tmprss2 by Tmprss-WT in flask cultures with similar IMAC (12). Based on the 
amount of Tmprss2 measured in individual elution fractions and unexpectedly 
low concentrations achieved in total concentrated fractions it was suspected 
that Tmprss2 was lost in the concentration step. This was finally demonstrated 
in Cycle 4 where the concentration of total dialyzed total fraction was measured 
before and after concentration. The concentration ratio was 10:1, but only 
increased the Tmprss2 concentration by roughly 2:1. The precipitate formed 
during the concentration was resuspended in 1 mL PBS and measured with 
NanoDrop and analysed with SDS-PAGE and WB. The resuspended precipitate 
was below measurement range on NanoDrop. The total concentrated fraction 
from Cycle 3.1 would be sufficient for crystallization by itself but the iterative 
methanol induction cultivation mode would allow for pooling the yields of 
consequent iterations together for even higher concentrations. This would be 
especially beneficial for preforming crystallization with the processed form 
Tmprss2 produced dominantly by the Tmprss-WT. 
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5.3 SDS-PAGE and Western blot results 
 
5.3.1 Cycle 0, Tmprss2-WT in 2 L Erlenmeyer flasks in fed-batch 
cultivation mode. 
 
 
Figure 20. Western blot detection of concentrated Tmprss2-WT fractions purified with 
IMAC from Cycle 0.  
In Cycle 0 the individual elution fractions were too diluted to give a signal on WB 
or SDS-PAGE or to be measured by spectrophotometry. After intensive 
concentration of 20:1 – 32:1 the peak fractions for 200 mM and 500mM buffers 
became visible on WB. 
Both materials used for IMAC showed positive results for Tmprss2 production 
and capture from supernatant. The signal from NiSepharose™excel was not 
only demonstrated to be suitable for Tmprss2 IMAC, but even had a stronger 
signal on the WB than Ni-NTA in this experiment. It could also be noted that 
most of the bound Tmprss2 was eluted already during the 200 mM imidazole 
elution. Tprss2-WT producing more of the processed variant of Tmprss2 was 
the expected result already observed in (12), but it was demonstrated once 
again with both IMAC materials showing bands only at approximately 30kDA.  
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5.3.2 Cycle 1, Tmprss2-WT in 2 L Erlenmeyer flasks in hybrid 
iterative methanol induction cultivation mode 
 
Figure 21. Western blot detection of Tmprss2-WT fractions purified with IMAC from Cycle 
1.1.  
 
In the first iteration of Cycle 1 Äkta start was used for automatic fractionation 
during IMAC and this resulted in more concentrated individual fractions visible 
on WB without concentration steps. The trend of having most of the Tmprss2 
eluted already in the first elution after washing was repeated also in Cycle 1.1 
with only weak signal from the 500 mM imidazole elution. 
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Figure 22. Western blot detection of concentrated Tmprss2-WT fraction purified with 
IMAC from Cycle 1.1. 
The four most potential fractions 7-10 from Cycle 1.1 were pooled together and 
successfully concentrated to produce a concentrated total fraction for the 
iteration. It is more likely that the imprints on lanes 3 and 4 are not actually from 
Cycle 1.2 elution fractions 13 and 14. It is far more likely that the signal seen 
there is caused by spillage or transfer from the strong signal on lane 2. 
 
 
 
50 
 
 
Figure 23. SDS detection of concentrated Tmprss2-WT fraction purified with IMAC from 
Cycle 1.1. 
The total concentrated fraction from Cycle 1.1. was strong enough to produce a 
clear signal also on SDS-PAGE. The gel in figure 26. was dried and the band at 
30 kDA on lane 2 was cut out and analyzed by mass spectrometry. Mass 
spectrometry confirmed the band to be mouse Tmprss2. This showed that the 
Tmprss2-WT cell line was producing the intended product and it was 
successfully captured by IMAC. 
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Figure 24. Western blot detection of Tmprss2-WT fractions purified with IMAC from Cycle 
1.2. 
The second iteration of Cycle 1 produced even stronger and more bands on WB 
than Cycle 1.1 most likely because of the increase of methanol feeding from 0.5 
to 1%(V/V) during the second iteration. The concept and results of iterative 
methanol induction already outlined in (12) were replicated. The full length 
ectodomain of Tmprss2 was also visible in the strongest signals for the Cycle 
1.2 fractions at 45 kDa especially in fraction 9 on lane 6. The total concentrated 
fraction for Cycle 1.2 produced a very weak signal on WB and was not 
detectable by spectrophotometry. While the individual fractions seen on lanes 2-
7 seem very strong, it is highly likely that most of the Tmprss2 was lost during 
concentration step resulting in the lackluster total concentrated fraction. 
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5.3.3 Cycle 2, Tmprss2-WT in 2 L Labfors 3 reactor in iterative 
methanol induction cultivation mode 
Loss of expression or failure to capture Tmprss2 was experienced in Cycle 2.  
   
5.3.4 Cycle 3, Tmprss2-Mut in 2 L Labfors 3 reactor in iterative 
methanol induction cultivation mode 
 
Figure 25. SDS-PAGE detection of Tmprss2-Mut fractions purified with IMAC from Cycle 
3.1. 
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Figure 26. Western blot detection of Tmprss2-Mut fractions purified with IMAC from 
Cycle 3.1. 
The Cycle 3.1 SDS-PAGE and WB seen in Figures 25 and 26 show results 
expected from Tmprss2-Mut cultivation based on the results in (12). Higher 
Tmprss2 was yielded demonstrated in Figure 26 by individual unconcentrated 
elution fractions being visible on SDS-PAGE, which was never the case for 
Tmprss2-WT. Most of the produced Tmprss2 D343N appears to be in the 45 
kDa uncleaved form although the weaker band of the processed form at 30 kDa 
is also visible. 
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Figure 27. Western blot detection of Tmprss2-Mut fractions purified with IMAC from 
Cycle 3.2. 
In the second iteration of Cycle 3 the Tmprss2 WB signal was at its highest 
throughout the thesis work. There also appeared to be leftover Tmprss2 in the 
culture supernatant after IMAC detected by a strong signal on lane 10 in Figure 
27. This supernatant sample was also run on a SDS-PAGE gel and the 
resulting band was sent to mass spectrometry for identification. The signal on 
lane 10 was identified as a P. pastoris cell wall protein and the similar molecular 
weight to Tmprss2 was merely a coincidence. Thus, the suspicion that there 
was a significant amount of Tmprss2 remaining in the supernatant after IMAC 
could be dismissed. 
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Figure 28. Western blot detection of concentrated Tmprss2-Mut fractions purified with 
IMAC from Cycle 3. 
The concentration of both Cycle 3.1 and 3.2 total fractions appears to have 
been equally successful. There only appeared to be trace amounts of Tmprss2 
in the precipitate formed during the concentration seen on lanes seven and nine 
showing that the Tmprss2 was not being lost in to the precipitate during 
concentration step.  
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Figure 29. SDS-PAGE detection of concentrated Tmprss2-Mut fractions purified with 
IMAC from Cycle 3. 
 
In Figure 29. the increase of contaminants from C3.1 to C3.2 can be observed. 
It also appears that separation of contaminants by precipitation during the 
concentration process was only successful in Cycle 3.2. 
 
 
 
 
 
 
 
57 
 
 
Figure 30. Western blot detection results of degradation and autocatalytic processing 
experiment by coincubation of C3.1 concentrated total fraction with 1:100 Cycle 1.1 
concentrated total fraction. 
It appears that adding only a fraction of the processed Tmprss2 to a higher 
amount of the unprocessed form of Tmprss2 and incubating them together at 37 
°C autocatalyzes the unprocessed Tmprss2 D343N in a matter of hours. This 
can be observed by the change of composition in the mix of Tmprss2 and 
Tmprss2 D343N in lanes 3,4 and 5. Based on the change of intensity between 
the bands at 45 and 30 kDa it would appear that for mixed fractions the 30 kDa 
band increases in intensity before deteriorating. The control of only Tmprss2 
D343N on lanes 7, 8 and 9 deteriorates at a steady rate without changes in its 
composition.  
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5.3.5 Cycle 4, Tmprss2-Mut in 2 L Erlenmeyer flasks in fed-batch 
cultivation mode 
 
Figure 31. Western blot detection of Tmprss2-Mut fractions purified with IMAC from 
Cycle 4. 
In Cycle 4 very prominent bands of also the processed 30 kDa Tmprss2 were 
produced. The intensity of the bands is well in line with the high individual 
spectrophotometry results of Cycle 4 fractions. The fraction 7 on lane 4 in 
Figure 31. represents by itself 1,488 mg of Tmprss2 D343N in a 2 mL fraction. 
This is a prime example of how the western blot and spectrophotometry results 
had a strong correlation with the high and narrow peak in UV-absorption during 
IMAC seen in Appendix 9.2.8.  
 
 
 
 
59 
 
5.4 Mass spectrometry results 
 
5.4.1 Cycle 1.1 concentrated total fraction 
Reference sequence: Tmprss2-WT [Mus musculus] 
(EAEAEFG)DSNCSTSEMECGSSGTCISSSLWCDGVAHCPNGEDENRCVRLY
GQSFILQVYSSQRKAWYPVCQDDWSESYGRAACKDMGYKNNFYSSQGIPDQ
SGATSFMKLNVSSGNVDLYKKLYHSDSCSSRMVVSLRCIECGVRSVKRQSRI
VGGLNASPGDWPWQVSLHVQGVHVCGGSIITPEWIVTAAHCVEEPLSSPRY
WTAFAGILRQSLMFYGSRHQVEKVISHPNYDSKTKNNDIALMKLQTPLAFNDL
VKPVCLPNPGMMLDLDQECWISGWGATYEKGKTSDVLNAAMVPLIEPSKCNS
KYIYNNLITPAMICAGFLQGSVDSCQGDSGGPLVTLKNGIWWLIGDTSWGSGC
AKALRPGVYGNVTVFTDWIYQQMRANSENLYFQGACDYKDDDDKHHHHHHH
H 
The sequences in brackets are the remainders of the secretion signal that might 
still be attached to the protein. The WT-Tmprss2 sequence TKNNDIALMK is 
highlighted with red in the total sequence. 
 
Result sequence: 
Sample ID: 615 blue 
>gi|74222080|dbj|BAE26858.1| unnamed protein product [Mus musculus] 
MALNSGSPPGIGPCYENHGYQSEHICPPRPPVAPNGYNLYPAQYYPSPVPQY
APRITTQASTSVIHTHPKSSGALCTSKSKKSLCLALALGTVLTGAAVAAVLLWR
FWDSNCSTSEMECGSSGTCISSSLWCDGVAHCPNGEDENRCVRLYGQSFIL
QVYSSQRKAWYPVCQDDWSESYGRAACKDMGYKNNFYSSQGIPDQSGATS
FMKLNVSSGNVDLYKKLYHSDSCSSRMVVSLRCIECGVRSVKRQSRIVGGLN
ASPGDWPWQVSLHVQGVHVCGGSIITPEWIVTAAHCVEEPLSSPRYWTAFAG
ILRQSLMFYGSRHQVEKVISHPNYDSKTKNNDIALMKLQTPLAFNDLVKPVCLP
SPGMMLDLDQECWISGWGATYEKGKTSDVLNAAMVPLIEPSKCNSKYIYNNLI
TPAMICAGFLQGSVDSCQGDSGGPLVTLKNGIWWLIGDTSWGSGCAKALRP
GVYGNVTVFTDWIYKQMRANS  
The WT-Tmprss2 sequence TKNNDIALMK highlighted with red in the total 
sequence, was also found in the result sequence. 
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Table 4. Theoretical molecular weights for the Tmprss2-WT sequence for an oxidized 
sample of the Tmprss2-WT. Values in red and blue were found in the spectra for the 
same sample seen in Figure 32. 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. Spectra for the oxidised sample of the Tmprss2-WT sample. 
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Peptid-ID: 2.0 
    no acid B [M+H]+ B [M+2H]2+ Y [M+H]+ Y [M+2H]2+ 
1 T 102,055 51,531 - - 
2 K 230,15 115,579 1062,561 531,784 
3 N 344,193 172,6 934,466 467,737 
4 N 458,236 229,622 820,423 410,715 
5 D 573,263 287,135 706,38 353,694 
6 I 686,347 343,677 591,353 296,18 
7 A 757,384 379,196 478,269 239,638 
8 L 870,468 435,738 407,232 204,12 
9 M 1017,503 509,255 294,148 147,578 
10 K - - 147,113 74,06 
sequence:TKNNDIALMK 
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Table 5 theoretical molecular weights for the Tmprss2-WT sequence for an unoxidized 
sample of the Tmprss2-WT. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33. Spectra for the unoxidized sample of the Tmprss2-WT sample. 
The suspected Tmprss2 band from Cycle 1.1 was confirmed by mass 
spectrometry to be Tmprss2. This confirmed that the cell line used was indeed 
Tmprss-WT. This was also an indicator for decent purity of the produced 
Tmprss2. 
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Peptid-ID: 3.0 
    no acid B [M+H]+ B [M+2H]2+ Y [M+H]+ Y [M+2H]2+ 
1 T 102,055 51,531 - - 
2 K 230,15 115,579 1046,566 523,787 
3 N 344,193 172,6 918,471 459,739 
4 N 458,236 229,622 804,428 402,718 
5 D 573,263 287,135 690,385 345,696 
6 I 686,347 343,677 575,359 288,183 
7 A 757,384 379,196 462,274 231,641 
8 L 870,468 435,738 391,237 196,122 
9 M 1001,508 501,258 278,153 139,58 
10 K - - 147,113 74,06 
sequence 
:TKNNDIALMK 
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5.4.2 Cycle 3.1 Supernatant post IMAC 
Reference sequence: Tmprss2-D343N [Mus musculus] 
(EAEAEFG)DSNCSTSEMECGSSGTCISSSLWCDGVAHCPNGEDENRCVRLY
GQSFILQVYSSQRKAWYPVCQDDWSESYGRAACKDMGYKNNFYSSQGIPDQ
SGATSFMKLNVSSGNVDLYKKLYHSDSCSSRMVVSLRCIECGVRSVKRQSRI
VGGLNASPGDWPWQVSLHVQGVHVCGGSIITPEWIVTAAHCVEEPLSSPRY
WTAFAGILRQSLMFYGSRHQVEKVISHPNYDSKTKNNNIALMKLQTPLAFNDL
VKPVCLPNPGMMLDLDQECWISGWGATYEKGKTSDVLNAAMVPLIEPSKCNS
KYIYNNLITPAMICAGFLQGSVDSCQGDSGGPLVTLKNGIWWLIGDTSWGSGC
AKALRPGVYGNVTVFTDWIYQQMRANSENLYFQGACDYKDDDDKHHHHHHH
H 
The sequences in brackets are the remainders of the secretion signal that might 
still be attached to the protein. The TKNNNIALMK sequence for mutant 
Tmprss2 D343N is highlighted with red in the total sequence. 
 
Result sequence:   
Sample ID: 616 blue 
>gi|254570889|ref|XP_002492554.1| hypothetical protein [Komagataella 
pastoris GS115]gi|238032352|emb|CAY70375.1| Hypothetical protein 
PAS_chr3_0337 [Komagataella pastoris] 
GS115]gi|328353433|emb|CCA39831.1| Cell wall protein CWP1 [Komagataella 
pastoris] 
MFNLKTILISTLASIAVADQTFGVLLIRSGSPYHYSTLTNRDEKIVAGGGNKKVT
LTDEGALKYDGGKWIGLDDDGYAVQTDKPVTGWSTNGGYLYFDQGLIVCTED
YIGYVKKHGECKGDSYGMAWKVLPADDDKDDDKDDDKDDDKDYDDDNDHG
DGDYYCSITGTYAIKSKGSKHQYEAIKKVDAHPHVFSVGGDQGNDLIVTFQKD
CSLVDQDNRGVYVDPNSGEVGNVDPWGELTPSVKWDIDDGYLIFNGESNFR
SCPSGNGYSLSIKDCVGGTDIGLKVWEK 
The band suspected to be Tmprss2 from Cycle 3.2 that had passed through 
IMAC in culture supernatant was identified to be a P. pastoris cell wall protein. 
There was no match for the TKNNNIALMK sequence for mutant Tmprss2 
D343N in the supernatant sequence. This only confirmed that all Tmprss2 was 
in fact captured in the IMAC process and that it appears that consecutive 
iterations did accumulate dead cell material in the culture. The accumulation in 
this case is observed as the P. pastoris cell wall protein CWP1. 
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6 Discussion 
 
6.1 Experimentation with both Tmprss2-WT and -Mut cell lines 
Initially only the Tmprss2-Mut strain was supposed to be used for experiments instead 
of both Tmprss2-Mut and Tmprss2-WT cell lines. The Tmprss2 yield from Tmprss2-WT 
cell line was so low based on results from (12), that it was considered not to have 
enough potential even though it produced Tmprss2 in the desired autocatalyzed active 
form. The autocatalyzed form having higher activity when incubated with H1 was 
considered the preferable one for crystallization over the mutant D343N form of 
Tmprss2 with lower activity. The Tmprss2-WT variant was cultivated in Cycles 0-2 by 
accident. Because it repeatedly produced Tmprss2 only in the processed form and did 
not have the growth kinetics of a MutS strain it was suspected not to be Tmprss2-Mut. 
This was confirmed by PCR analysis from the preculture of Cycle 2. After being 
confirmed as the wrong cell line the next experiment named Cycle 3 was started by 
plating Tmprss2-Mut from stock culture sample from -80°C storage. The preculture 
used in Cycle 3 was then confirmed by PCR analysis to be Tmprss2-Mut. Because of 
this unintended experimentation with Tmprss2-WT cell line some additional time was 
spent wrestling with unexpected results. This extra time and the time spent on the 
experiments themselves set a very limited schedule for laboratory work for this 
bachelor’s thesis. The limited amount of time available led to little possibility for 
repeating or streamlining already successful experiments, but experimentation with 
both cell lines made comparison between the two possible and enabled conducting the 
autocatalytic processing experiment by coincubation of autocatalyzed Tmprss2 in 
1:100 ratio with mutant D343N Tmprss2 in Cycle 3.1. The Tmprss2-WT was also found 
to have higher potential for producing ample amounts for crystallization than was 
originally thought based on (12). 
 
6.2 Error evaluation 
High optical density of P. pastoris cultures required dilutions up to 1:1000 to be 
quantifiable by the measurement devices. Such high dilution ratios even when 
conducted in larger volumes of 10 mL and in series are susceptible to high 
measurement error. Measurement error may be magnified significantly in the 
repeated dilution steps. Precipitation or the lack of it could cause changes in 
turbidity resulting in incorrect OD values. 
Strong UV absorbance of imidazole caused background issues in 
spectrophotometry even when respective imidazole buffers were used as blank 
reference. This made dialysis necessary prior to spectrophotometry and 
especially lower quantities of Tmprss2 would have been more accurately 
quantified after dialysis. 
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6.3 Hardware failures 
In Cycle 1 the cable for connecting the methanol sensor and feed pump was 
found to be damaged and automatic feeding could not be established. This led 
to the reactor culture being transferred into 2 L flasks and cultivated in a hybrid 
approach. The AF sensor of the reactor experienced over sensitivity issues as 
individual droplets could hit the sensor and cause AF feeding in to the reactor 
needlessly. In methanol induction phase where the methanol itself works as an 
AF agent the AF sensor was manually turned off if it caused unnecessary AF 
feeding. Addition of the AF-agent 5% (V/V) Struktol J 673 meant addition of 
methanol as this AF agent was dissolved and diluted in methanol. All flasks 
excluding precultures which were in smaller volume and produced less foam 
were thus run in mixed feed with an initial charge of approximately 0.095% 
(V/V) methanol. The AF Struktol J673A has also been observed to increase 
recombinant protein expression and secretion in P. pastoris (26). The 
calibration of the methanol sensor was slightly affected by the extra methanol 
causing the set point in reactor to be higher than 0.5%(V/V). 
The culture from Cycle 2.3 was spoiled during the centrifugation step as the 
centrifuge lid’s magnetic lock malfunctioned, causing the culture to stay in the 
centrifuge and in room temperature for more than 12 h. The batch was 
presumed to be spoiled after such a long time and was discarded. 
 
6.4 Semi-sterile working conditions and contamination 
The cultivation methods for repeated iterations cannot be considered entirely 
sterile as the culture was removed from the sealed reactor. The culture was 
transferred into clean, but not sterile centrifuge flasks which were open for 
balancing prior to centrifugation. Another significant breach of sealed reactor 
conditions occurred in Cycle 3 where the membrane in the methanol probe was 
ripped during assembly and had to be replaced after the reactor had already 
been autoclaved. 
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Figure 34. Reactor contamination seen as a yellow culture adhering to the reactor wall 
and baffle. 
During Cycle 3.3 an anomaly was detected adhered to the reactor wall. A 
sample was taken from the reactor for microscopy and plating. During 
microscopy at x1000 magnification only yeast cells could be seen in the sample. 
The sample was plated on YPD plates with and without ampicillin. After an 
overnight incubation at 30°C unknown microbial growth was detected on both 
plates. Because of the fast growth rate and ampicillin resistance of the 
contaminating organism it was presumed to be a laboratory strain of 
Escherichia coli. After the contamination was confirmed the cultivation was 
stopped and the reactor was directly autoclaved with its contents. 
 
6.5 IMAC issues 
In general, the Äkta start system with NiSepharose™excel material column 
worked well with slow flowrates and overnight loading. Using the system was a 
significant improvement over the simple setup for Cycle 0 which was mostly 
manual. The Äkta start system featured constant measurement and real-time 
datalogging of UV-absorbance, flow rate, elution buffer gradient, conductivity 
and pressure. The greater amount of real time and recorded information as well 
as the automatic fractioning of the elution fractions made evaluating the process 
easier and diagnosing issues possible as they occurred. The best example of 
this can be seen in Appendix 9.2.2 Chromatogram Cycle 1.2. IMAC in Cycle 1 
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suffered from increased back pressure and eventually blocking of the sampling 
flow path due to precipitation of reactor media components in the culture 
supernatant. The precipitation was increased when the pH of the culture 
supernatant was adjusted above 6 as was recommended for using 
NiSepharose™excel material by the manufacturer. This lead to failure to collect 
the fractions from the C1.2 supernatant cultivated with iteration method B as the 
IMAC had to be aborted and Äkta start washed due to tubing being blocked by 
precipitate. During the following Cycles the pH was not adjusted as it was 
already in the range of 5.8-6 and considerably less precipitation occurred. 
It appeared that the expression of Tmprss2 was lost or the capture of the 
protein was unsuccessful IMAC in Cycle 2. No Tmprss2 was detected in the 
elution fractions by SDS-PAGE or WB in Cycle 2.1. This is likely caused by 
used error where the fractionation was started too late and the peak elution 
fractions were pumped into waste instead of being collected. The values for UV-
absorbance in Cycle 2.1 IMAC seen in Appendix 2.4 followed the same pattern 
as they did in the IMAC for other Cycles i.e. Cycle 3.2 Appendix 9.2.6 where 
Tmprss2 was detected WB. The higher initial peak when 200 mM Imidazole 
buffer is pumped through the column which then logarithmically levels to a 
plateau was a repeated pattern in all elutions, but it was the clearest in elution 
with 200 mM imidazole elution buffer. This pattern seems to be indicative of 
material first being eluted off the column and then the UV absorbance settling to 
the level caused by the imidazole, which corresponds well with the fact that the 
first fractions during the initial peak in 200 mM imidazole elution also gave the 
strongest signal for Tmprss2 both on WB and in photospectrometry. The same 
pattern was observed also when introducing 500 mM imidazole elution buffer to 
the column except the difference between the peak and the level UV-
absorbance it settles to afterwards was considerably smaller. This is well in line 
with what was detected with WB and spectrophotometry where most of the 
Tmprss2 is seen eluted as a gradient mostly during 200 mM imidazole elution 
and again during 500 mM imidazole elution, but only in in trace amounts. 
Considering the recorded UV-absorbance graph seen in Appendix 9.2.3 it is 
likely that Tmprss2 was produced in C2.1, but it simply wasn’t successfully 
fractionated from IMAC due to user error. In Cycle 2.2 Tmprss2 was not 
detected on WB or with spectrophotometry and loss of expression was 
suspected once more. It is more likely that the reason was failed IMAC once 
again. Because of the known tendency of Tmprss2 to degrade if not stored in at 
least 4°C an improvement was tested on C2.2 IMAC. Instead of letting the 
culture supernatant stay in RT the Schott flask containing the culture 
supernatant being loaded onto the column overnight was placed in a bucket 
filled with ice. Unfortunately, as the ice meted the bottle started to float at an 
angle where the intake tube for sample loading was not submerged and air was 
pumped onto the column for several hours. This can be seen in the Appendix 
9.2.4 where the UV-value is not steady but very unstable for a large portion of 
the loading phase while air is being pumped onto the column. The drying of the 
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column would have likely caused the loss of the Tmprss2 already bound during 
loading. When the issue was discovered the loading was directly continued by 
resubmerging the intake tubing and levelling the bottle. This was not enough as 
the dry column would not be able to bind the consequently loaded Tmprss2 
without being first saturated with alcohol to remove the air and then equilibrated 
with equilibration buffer.  
Some of the produced Tmprss2 would have likely degraded during IMAC as 
well. IMAC was conducted overnight in room temperature likely resulting in loss 
of Tmprss2. This may be a reason for the higher Tmprss2 yields per culture 
supernatant volume used in IMAC in Cycle 0 where IMAC was conducted in a 
few hours instead of an overnight process. The reason for using such a long 
loading process with the Äkta start system in comparison to the Cycle 0 setup 
was that the volume of the column was slightly smaller 5 mL instead of 6 mL 
while the volume of culture supernatant was more than double the volume 
compared to the 500 mL in Cycle 0. Because of the time-consuming preparation 
of the culture supernatant by centrifugation and filtration steps it was not 
possible to complete the preparation and IMAC during a single day. The 
solution to the loading phase in the IMAC process with Äkta start often taking 
10h or longer was conducting it overnight. 
An alternative to using NiSepharose™ excel in a column could be adding it 
directly in to the supernatant after filtration.  The supernatant with 
NiSepharose™ excel could then be left for capture overnight in 4°C while being 
end over end mixed. The NiSepharose™ excel could be separated after the 
overnight incubation by centrifugation at 4°C. After separation, the 
NiSepharose™ excel material with bound Tmprss2 could be resuspended in 
200 mM imidazole buffer for elution. Once separated again from the liquid 
fraction by centrifugation the excel material could be renewed by equilibration 
and stored in ethanol for future use. The Tmprss2 now eluted in the imidazole 
buffer would then be ready for dialysis and analysis by SDS-PAGE, WB and 
spectrophotometry. Using this method would allow preforming the entire IMAC 
process in 4°C avoiding Tmprss2 degradation while allowing hours of contact 
between the culture supernatant and the resin material. This method also has 
no risk of disrupting the column with either air or precipitate as the 
NiSepharose™ excel material is floating freely in the culture supernatant. Same 
could be achieved by moving the entire Äkta start IMAC setup into a cold room 
at 4°C, but the issues with precipitation would likely only increase with this 
option as solubility decreases in low temperature. 
 
68 
 
 
6.6 Loss of protein during concentration 
It would appear that some of the produced Tmprss2 was always lost in the 
concentration step. This was observed by comparing the individual fractions 
and the final concentrated total fraction as well as the total fraction prior to 
concentration. The clearest indication of protease loss during concentration was 
demonstrated in Cycle 4 where a lot of Tmprss2 from the dialyzed 
unconcentrated total fraction was lost during the concentration step. The initial 
amount of Tmprss2 in the unconcentrated total fraction for Cycle 4 was 4,78 mg 
in 10 mL volume. After 10:1 concentration the amount was only 0,959 mg in 1 
mL volume. The Tmprss2 concentration was increased roughly 2:1 in 10:1 
concentration while it appears most of the Tmprss2 was lost This gives reason 
to assume that the actual amounts of Tmprss2 produced would be higher than 
the final values measured after concentration seen in Table 3. The loss of 
Tmprss2 in the concentration step could be countered by utilizing a different 
concentration technique that does not cause such high loss of Tmprss2. 
 
6.7 Precipitation issues 
The standard single-cell protein media recipes work with recombinant strains. 
However, they are not perfect or unoptimizable. The precipitation of the salts 
occurs during steps such as medium preparation, combining base medium and 
hexametaphosphate fraction in the reactor and IMAC. The salts may also 
precipitate in high cell densities without it being detected causing error in cell 
density measurement through OD because of the increased turbidity caused by 
precipitated salts (21). One approach to solving this issue would be reducing 
the concentration of salts in the basalt salt medium to ¼ of the amounts given in 
the recipe (27). This reduction has been observed to have no negative influence 
on cell growth rate, biomass yield or the level of recombinant protein production 
(29). 
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6.8 Running reactor in ultra-high cell density conditions  
The production of Tmprss2 could likely be improved by running the reactor in 
ultra-high cell density conditions in the range of OD> 500; WCW >400 g/L which 
were not reached with the method aimed for mitigating the time needed for each 
cultivation step used in this thesis work. The ultra-high cell density conditions 
would be achievable by prolonging the glycerol feed phase and using additional 
oxygen in the air flow to keep pO2 above 20%. The higher cell density culture 
would likely consume methanol at a higher rate compared to the lower cell 
densities used. This should result in greater amounts of produced Tmprss2 in 
the culture supernatant. The iterative methanol induction cultivation mode 
makes reaching the ultra-high cell density more efficient as the cell density is 
retained from the initial iteration to the following ones mitigating the effect of the 
additional time required for the glycerol feed phase. 
 
6.9 Continuous cultivation with perfusion membrane for 
harvesting and direct IMAC with a two-line semi-
continuous setup 
When moving forward with cultivation techniques the semi continuous iterative 
cultivation mode could be developed further into a truly continuous one. The 
harvesting phase interrupting cultivation every 48h and causing stress as well 
as a lag phase in the cell growth could be avoided by utilizing a perfusion 
membrane. The culture supernatant could be collected through this perfusion 
membrane while leaving the cells in the reactor at a rate keeping the volume of 
the reactor constant. The reactor volume could be exchanged faster by using 
mixed feeding of methanol feed and the reactor media. The reactor media used 
in feeding could contain lower concentrations of its components compared to 
the reactor media initially used to fill the reactor for glycerol phase as it would 
have only 48h retention time in the reactor. The continuous flow from this 
system could be filtrated and directed onto a two-line IMAC system where one 
column would be in loading phase while the other one is going through elution 
and renewal phases. By alternating between the two columns there would be no 
need to pause the IMAC process regardless of the need to pump other 
materials on the column separately from the culture supernatant during elution 
and renewal steps. This continuous process would minimize Tmprss2 
degradation over time by quick loading of the culture supernatant directly from 
the reactor to the column and remove the cell harvesting step entirely.    
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7 Conclusions 
 
NiSepharose™excel was repeatedly demonstrated to be a robust material for 
Tmprss2 IMAC. No issues with stripping of the immobilized nickel ions from the 
NiSepharose™excel was observed at any point. In comparison, the Ni-NTA 
column used for Cycle 0 was completely stripped by the culture supernatant in a 
single IMAC run. The issue with stripping the Ni-NTA column could be 
countered by adding nickel directly into the supernatant in the form of nickel 
sulphate prior to IMAC. The NiSepharose™excel material was capable of 
preforming direct IMAC without the addition of nickel sulphate and presented 
strong binding capability proving to be the better option for IMAC. The same 
HisTrap™ excel 5 mL column could be used for IMAC throughout this thesis 
work. The column required maintenance because of incidents in which air or 
precipitate was pumped onto the column. The column only had to be inverted, 
saturated with ethanol and equilibrated in between rounds of IMAC to keep it 
from being blocked or getting dry. Despite the stress to the column it was still 
functioning exactly as intended.  
The iterative methanol cultivation mode was shown to work in reactor scale in 
Cycle 3. The process could also be optimized by adding pure oxygen to the 
airflow during glycerol growth phase to shorten the feeding phase from an 
overnight process to approximately six hours. The additional oxygen removes 
dissolved oxygen limitation and allows glycerol feed to be fed to the reactor at 
an increased flow rate. This would also enable opting out for running the reactor 
in ultra-high cell density conditions higher than what was done with this method 
optimized for shortening the time to reach the induction phase.  
While the fresh media and the reactor cultivation setup provide everything 
required for maintaining the culture, in theory the iterations could be repeated 
limitlessly without losing expression creating a semi continuous process. 
However, build-up of dead cell material or other material contained in the cell 
pellet can cause issues as well as unused media or feed components as some 
are always left in the remaining 1/3 reactor volume in each iteration.  Building 
up of material can cause precipitation in the reactor and purification steps as 
well as increased need for filtration of supernatant for downstreaming. In cases 
of build-up of media components their concentration can be checked between 
each iteration or measured real time for example in the case of salinity. The 
concentrations can then be adjusted accordingly in the fresh media added 
between iterations. Dilution of media can also occur if the 1/3 remainder has 
been depleted. This could also be countered by increasing the concentrations of 
media components in fresh media added between iterations. The build-up of 
materials in the cell pellet or the cell density itself can be controlled by the 
amount of WCW that is returned to the reactor. 
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Removing the cells from the sealed reactor as well as inserting them back 
increases the risk of contamination. However, this risk is somewhat reduced by 
the high cell density of P. pastoris at expression phase. The risk of 
contamination can be further reduced by sterile working conditions and adding 
antibiotics into the reactor media.   
Tmprss2 was produced in scale of several mg which was the target for creating 
material which could be further purified for crystallization experiments. Highest 
total yield after concentration in a single iteration was reached in Cycle 3.2 (1,92 
mg) as seen in Table 3. This can be considered close enough to the target 2 
mg. Even higher total yield of 4,78 mg was present in the total fraction of Cycle 
4 prior to concentration. However, the quality of the Tmprss2 D343N after only 
the initial purification was far from homogeneous and would require more 
processing before reaching quality suitable for crystallization. The fast 48h 
production cycle in iterative methanol induction mode would allow pooling the 
produced Tmprss2 from several successive iterations to reach higher 
concentrations either prior to or after IMAC. Pooling the products of several 
iterations would make crystallization of the desired autocatalyzed form of 
Tmprss2 produced by the Tmprss2-WT cell line possible. The issue with the 
purity of Tmprss2 D343N produced by Tmprss2-Mut could potentially be 
countered with using processed Tmprss2 produced with WT-Tmprss2. 
Autocatalyzing the uncleaved from with lower activity to process it to the 
truncated form with higher activity would reduce the amount of iterations 
required to reach ample amounts of active Tmprss2 for crystallization. Perhaps 
the simplest way to increase production of Tmprss2 following this thesis work 
would be upscaling the reactor. The developed cultivation strategy for P. 
pastoris cell lines in 2 L scale using a bioreactor in iterative methanol induction 
cultivation mode should be applicable also in larger reactors. The larger reactor 
volume should result in a higher total yield of Tmprss2 for each iteration.  
 It was observed that much of the protein is lost during concentration the elution 
fractions. This could be optimized by using a more sophisticated concentration 
technique i.e. repeated IMAC, diafiltration or TCA precipitation. 
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9 Appendices 
 
9.1 Appendix 1. Reactor logs 
76 
 
9.1.1 Reactor log Cycle 1. Tmprss2-WT glycerol growth phase in 2 L 
Labfors 3 reactor. 
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9.1.2 Reactor log Cycle 2. Tmprss2-WT in 2 L Labfors 3 reactor 
iterative methanol induction cultivation mode 
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9.1.3 Reactor log Cycle 3. Tmprss2-Mut in 2 L Labfors 3 reactor iterative 
methanol induction cultivation mode 
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9.2 Appendix 2. Äkta start IMAC logs 
 
UNICORN start 1.0 
 
16.06.2017 15:53:23 +02:00 
 
Result: WT 20170616 Run 2 
 
9.2.1 Chromatogram Cycle 1.1 
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UNICORN start 1.0  
22.06.2017 12:29:34 +02:00  
Result: Tmprss 2 mut 20170621 Run3  
 
9.2.2 Chromatogram Cycle 1.2 
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06.07.2017 13:24:00 +02:00 
 
UNICORN start 1.0 
 
22.06.2017 12:28:07 +02:00 
 
Result: Tmprss2 WT 20170622 Run4 
 
9.2.3 Chromatogram Cycle 2.1 
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UNICORN start 1.0 
 
28.06.2017 13:19:11 +02:00 
 
Result: Manual Run Cycle 2.2 
 
9.2.4 Chromatogram Cycle 2.2 
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UNICORN start 1.0 
 
01.07.2017 17:22:50 +02:00 
 
Result: Cycle 3.1 TLI17 
 
9.2.5 Chromatogram Cycle 3.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UNICORN start 1.0 
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03.07.2017 11:58:19 +02:00 
 
Result: Cycle 3.2 TLI17 
 
9.2.6 Chromatogram Cycle 3.2 Loading 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UNICORN start 1.0 
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04.07.2017 11:54:04 +02:00 
 
Result: Cycle 3.3 elution TLI17 
 
9.2.7 Chromatogram Cycle 3.2 Elution 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UNICORN start 1.0 
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09.07.2017 21:15:11 +02:00 
 
Result: Cycle 4 TLI17 
 
9.2.8 Chromatogram Cycle 4 
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9.3 Appendix 3 Materials list 
9.3.1 Laboratory equipment 
Purpose Make Model Checked on Variations 
Air Filters for reactor Gelman 
ACRODISC CR 
PTFE 0.2 um N/A N/A 
Balance 
Sartorius 
analytic BP 3100 S N/A N/A 
Beaker 
VWR/Schott 
Duran N/A N/A 50ml-2L 
Biological Safety 
Cabinet 
Thermo Fisher 
Scientific HerasafeKS 15 30/9/2016 N/A 
Bioreactor Infors AG 
Labfors 3  2 l 
fermentor system 28/07/2017 N/A 
Centrifuge for small 
scale 
Thermo Fisher 
Scientific 
Heraeus Fresco 
17 centrifuge 6/2017 N/A 
Centrifuge for 
harvest 
Thermo Fisher 
Scientific 
Sorvall RC 6+ 
Centrifuge 13/10/2016 N/A 
Centrifuge for 
concentration 
Thermo Fisher 
Scientific 
MULTIFUGE 35-
s 7/2014 N/A 
Cold storage -20 °C Liebherr Öko Super 1/6/2017 N/A 
Cold storage 4 °C Liebherr SN-ST 6/2017 N/A 
Cold storage -80 °C  Sanyo 
Ultra low freezer 
MDFU53V N/A N/A 
Cooling circulator Julabo F34 6/2017 N/A 
Corning®  centrifuge 
tubes 
Sigma-Aldrich 
Co. 
Corning®  
centrifuge tubes N/A 15 - 50 ml 
Electrophoresis cell 
Bio-Rad 
Laboratories N/A N/A N/A 
Electrophoresis 
power source 
Bio-Rad 
Laboratories PowerPacc Basic 6/2017 N/A 
Erlenmeyer flask Schott Duran N/A N/A 20ml-2L 
Filters for vacuum 
filtration0.45 um 
Sartorius 
Stedim Biotech 
Gmbh 
Cellulose Acetate 
Filter N/A N/A 
Fume hood HESCO Labcontrol 2016 N/A 
Glockfilters for 
sterile filtration Sartolab-P20 Sartolab-P21 N/A N/A 
High accuracy 
balance 
Sartorius 
analytic 200 S N/A N/A 
Incubation chamber 
30°C gbf heraeus  b20 6/2017 N/A 
Incubation chamber 
37°C gbf heraeus  b20 6/2017 N/A 
Inkscape software 
Open Source 
Software Version 0.92.2 N/A N/A 
IRIS- software Infors N/A N/A N/A 
Laboratory coat N/A N/A N/A N/A 
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Magnetic stirrers Heidolph MR 3001 6/2017 
100-1200 
Rpm 
Measuring cylinder Vitlab N/A N/A N/A 
Membrane tubes for 
dialysis Spectrumlabs 
SpSpectra/PorTM 
dialysis tubes 6000-8000 MWCO N/A 
Methanol sensor & 
probe 
Raven 
biotechnick 
Methanol 
Detector and 
Sensor 6/2017 N/A 
Millipore water 
system MERCK Advantage A10 N/A N/A 
Mixers for staining Biometra WT 12 6/2017 5-50 Rpm 
MS Office package 
software 
Microsoft 
Corporation 2016 Version N/A N/A 
NanoDrop 
Thermo Fisher 
Scientific NanoDrop 2000c 6/2017 N/A 
NanoDrop software 
Thermo Fisher 
Scientific Version 1.4.2 N/A N/A 
Nitrile glowes 
Starlab 
International 
GmbH 
Star guard 
comfort N/A N/A 
OD meter  Biochrom Ltd 
WPA CO 8000 
Biowave Cell 
Density Meter 6/2017 N/A 
pH-meter reactor Mettler Toledo 
165 DPAS 
SCKBS22 N/A N/A 
pH-meter 
Metler Toledo 
Laborph Sevenmulti S40 6/2017 N/A 
Pipettes Gilson Pipetman N/A 1-1000 
Pipetus autopipette 
Hirschmann 
Laborgeräte Pipetus N/A N/A 
Reusable bottle top 
filter unit Nalgene Co. 
NALGENE 
Reusable bottle 
top filter unit N/A N/A 
Polyvinylidene 
difluoride (PVDF) 
membrane  MERCK Immobilon-P N/A N/A 
Premade SDS gels 
Bio-Rad 
Laboratories 
Mini-PROTEAN 
precast gels N/A N/A 
Pump for Cycle 0 
affinitycapture Watson Marlow 101U 6/2017 N/A 
Pump for Glycerol 
and Methanol feed Watson Marlow 101U 6/2017 N/A 
Pump for manual 
capture Watson Marlow 101U 6/2017 N/A 
Pump for sterile 
filtration Ismatec Masterflex 6/2017 N/A 
Pump for vacuum 
filtration 
KNF LAB 
LABPORT N/A 6/2017 N/A 
Reaction caps 
(EPI's) Ependorf N/A N/A 1.5-2 ml 
Reactor pO2 Meter Mettler Toledo  pO2 probe N/A N/A 
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Safety goggles N/A N/A N/A N/A 
Scanner Canon  
CanoScan LiDe 
700F 6/2017 N/A 
Schott flask Schott Duran N/A N/A 50ml-2L 
Self packed column 
Bio-Rad 
Laboratories 
Econo-Column® 
Chromatography 
Column, 5.0 × 30 
cm N/A N/A 
Shaken incubation 
chamber 28C Infors Multitron 2/50 N/A N/A 
UNICORN start 
software 
GE Healthcare 
Bio-Sciences  
AB Version 1.0 N/A N/A 
UV-meter Cycle 0 
Bio-Rad 
Laboratories 
Econo UV-
Monitor 6/2017 N/A 
WesternBlot device 
turbo 
Bio-Rad 
Laboratories 
Trans-Blot Turbo 
transfer system 6/2017 N/A 
Vivaspintubes 
GE Healthcare 
Bio-Sciences  
AB Vivaspin 
5000-10000 
MWCO N/A 
Volumetric glass 
pipettes 
Hirschmann EM 
techcolor N/A N/A 5-20 ml 
Vortexer Heidolph Reax top 6/2017 N/A 
Äkta start 
GE Healthcare 
Bio-Sciences  
AB Äkta start 6/2017 N/A 
 
9.3.2 Chemicals and reagents 
Chemical/Product 
name Chemical Formula Producer Lot/Charge 
Expiration 
date 
All Blue Precision Plus 
Protein standard 
 
Bio-Rad 
Laboratories #161-0373 27/01/2017 
Ammonium NH4 
Carl Roth 
GmbH + Co. 
KG 345232536 28/07/2019 
Ammonium sulfate (NH4)2SO5 
Carl Roth 
GmbH + Co. 
KG EG2319841 N/A 
Anti-MouselgG (H+L), 
Ap Conjugate Secondary anti-body 
Promega 
Corporation 154632 28/10/2016 
BCIP/NBT Color  
Development 
Substrate 
 
Promega 
Corporation 242752 13/06/2019 
Bromphenol blue C19H10Br4O5S 
Stock solution 
from HZI N/A N/A 
Calcium Sulfate 
Dihydrate CaSO4x2H2O Merck KGaA TA285661814 N/A 
cOmplete Mini, EDTA 
free Protease inhibitor 
cocktail tablets N/A 
Roche 
Diagnostics 
GmbH 14584200 7/2017 
d-Biotin Vitamin H 
Sigma-Aldrich 
Co. 092K0703 N/A 
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Dipotassium 
phosphate K2HPO4 
Carl Roth 
GmbH + Co. 
KG 493208006 27/11/2017 
Disodium phosphate Na2HPO4 
AplliChem 
Gmbh -An ITW 
Company 5l015167 9/2020 
Dithiothreitol C4H10O2S2 
Stock solution 
from HZI N/A N/A 
Ethanol C2H6O J.T Bakerr B.V. 1614105017 01/06/2021 
Glycerol 100% (HOCH₂)₂CHOH Merck KGaA K48734892706 N/A 
Glycine C2H5NO2 
Carl Roth 
GmbH + Co. 
KG 246244253 11/05/2020 
HisTrap™ excel 5ml N/A 
GE Healthcare 
Bio-Sciences 
AB 10248029 5/2018 
hydrogen chloride HCL 
Carl Roth 
GmbH + Co. 
KG 5042229 26/11/2018 
Imidazole C3H4N2 
AplliChem 
Gmbh -An ITW 
Company 3K007109 N/A 
Instant Blue 
Coomassie staining 
solution for protein 
gels Expedeon Ltd. 161013100 10/8/2018 
Magnesium chloride MgCl2 
Carl Roth 
GmbH + Co. 
KG 329108174 N/A 
Magnesium sulfate 
heptahydrate MgSO4x7H2O J.T Bakerr B.V. F46162 N/A 
Methanol 100% CH3OH J.T Bakerr B.V. 1421906005 10/9/2019 
Monopotassium 
phosphate KH2PO4 
Carl Roth 
GmbH + Co. 
KG 55223744 22/12/2018 
Monopotassium 
phosphate KH2PO4 
Carl Roth 
GmbH + Co. 
KG 246244041 11/05/2020 
Mouse α-Flag   Primary anti-body 
Sigma-Aldrich 
Co. N/A 26/11/2019 
Ni-NTA His-Bind N/A Novagen N/A N/A 
NiSepharose™excel  N/A 
GE Healthcare 
Bio-Sciences 
AB 10247257 5/2019 
Nonfat dried milk 
powder N/A 
AplliChem 
Gmbh -An ITW 
Company 4S008807 N/A 
Peptone N/A 
BD Biosciences 
Advanced 
Bioprocessing 1033562 11/02/15 
Potassium chloride KCL 
Carl Roth 
GmbH + Co. 
KG 446250961 10/2020 
Potassium hydroxide KOH 
Carl Roth 
GmbH + Co. 
KG 488101723 N/A 
Potassium sulfate K2SO5 Merck KGaA AM0971053703 N/A 
PTM1 trace salts 
Stock solution from 
HZI N/A from 05022015 N/A 
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Sodium azide NaN3 
Stock solution 
from HZI N/A N/A 
Sodium chloride NaCl 
Carl Roth 
GmbH + Co. 
KG 486252534 28/11/2020 
Sodium dodecyl 
sulfate NaC12H25SO4 N/A N/A N/A 
Sodium dodecyl 
sulfate NaC12H25SO4 
Stock solution 
from HZI N/A N/A 
Sodium hydroxide NaOH 
Sigma-Aldrich 
Co. SZBE3500V N/A 
SodiumHexameta 
Phosphate (NaPO3)6 
Sigma-Aldrich 
Co. BCBN0343V N/A 
Struktol J 673 AF-agent 
Richard Sichler 
Chemikalien 
GmbH N/A N/A 
Tris hydrochloride NH2C(CH2OH)3xHCl  
Sigma-Aldrich 
Co. SLBN8819V N/A 
Tris hydrochloride NH2C(CH2OH)3xHCl  
Stock solution 
from HZI N/A N/A 
Tri-Sodium phosphate Na3PO4 Merc KGaA K44157272321 N/A 
TWEEN 20 
(Polyoxyethylene (20) 
sorbitan monolaurate) C58H114O26 
Bio-Rad 
Laboratories 117851C N/A 
Yeast extract N/A 
BD Biosciences 
Advanced 
Bioprocessing 4339796 31/10/2019 
Yeast Nitrogen Base 
Without Amino Acids 
(YNB) N/A Invitrogen 160114022101 N/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
